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Optical Coherence Tomography (OCT) provides non-labeling, real-time and 
high resolution images, which has the potential to transform the paradigm of surgical 
guidance and preclinical animal studies. The design and development of OCT devices 
for neurosurgery guidance and novel imaging algorithms for monitoring anti-cancer 
therapy have been pursued in this work. A forward-imaging needle-type OCT probe 
was developed which can fit into minimally invasive tools (I.D. ~ 1mm), detect the 
at-risk blood vessels, and identify tissue micro-landmarks. This promising guidance 
tool improves the safety and the accuracy of needle-based procedures, which are 
currently performed without imaging feedback. Despite the great imaging capability, 
OCT is limited by the shallow imaging depth (1-2 mm). In order to address this issue, 
the first MRI compatible OCT system has been developed. The multi-scale and multi-
contrast MRI/OCT imaging combination significantly improves the accuracy of intra-
operative MRI by two orders (from 1mm to 0.01 mm). In contrast to imaging systems, 
a thin (0.125 mm), low-cost (1/10 cost of OCT system) and simple fiber sensor 
technology called coherence gated Doppler (CGD) was developed which can be 
integrated with many surgical tools and aid in the avoidance of intracranial 
hemorrhage. Furthermore, intra-vital OCT is a powerful tool to study the mechanism 
of anti-cancer therapy. Photo-immunotherapy (PIT) is a low-side-effect cancer 
therapy based on an armed antibody conjugate that induces highly selective cancer 
cell necrosis after exposure to near infrared light both in vitro and in vivo. With novel 
algorithms that remove the bulk motion and track the vessel lumen automatically, 
OCT reveals dramatic hemodynamic changes during PIT and helps to elucidate the 
mechanisms behind the PIT treatment. The transformative guidance tools and the 
novel image processing algorithms pave a new avenue to better clinical outcomes and 
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Chapter 1: Introduction 
1.1 Motivation 
1.1.1 Neurosurgery 
Navigating instruments accurately and safely to deep brain targets significantly 
impacts the therapeutic outcome of stereotactic neurosurgery. A fundamental 
limitation of needle-based stereotactic neurosurgeries, such as biopsy [1, 2], 
catheterization [3, 4], and electrode placement [5, 6] is that they are blind procedures 
in which the operator does not have real-time feedback as to what lies immediately 
ahead of the advancing instrument. This results in several problems:  
I. Numerous medium sized blood vessels which cannot be detected by CT and 
MRI are at risk of being lacerated by the advancing probe. Lacerated vessels in the 
brain can lead to stroke and death [7-9].  
II. The discrepancy between the actual position of the gray matter targets and its 
pre-operatively determined coordinate caused by inaccuracy of imaging navigation, 
intra-operative positioning issues and loss of cerebrospinal fluid can lead to false 
biopsy [10], failure of surgery [11] and severe adverse events [12].  
III. Connectomic surgery that can restore many brain diseases by stimulating 
specific neural fiber tracts [13-15] also requires precise intra-operative guidance to 
locate the pathology-related fiber tracts. Electrode misplacement by a few mm would 




In order to address the challenges of performing stereotactic neurosurgery safely 
and accurately, several intra-operative optical guidance tools have been developed 
and tested with in vivo large animal experiments in this study.   
1.1.2 Photoimmunotherapy 
Photo-immunotherapy (PIT) is a low-side-effect cancer therapy based on an 
armed antibody conjugate that induces rapid cellular necrosis after exposure to near 
infrared light. The conjugate consists of a hydrophilic photosensitizer phthalocyanine 
dye, IR700, which is covalently bound to a humanized monoclonal antibody. When 
exposed to near-infrared light, the conjugate induces highly selective and rapid cancer 
cell death both in vitro and in vivo [16, 17]. Selective destruction of perivascular 
cancer cells while leaving most of tumor blood vessels unharmed leads to 24-fold 
greater accumulation of nanomaterials in the tumor bed and significantly improves 
the efficacy of a nano-anti-cancer drug [18]. This effect is termed super-enhanced 
permeability and retention (SUPR). Histology and fluorescence images confirm that 
high concentration of non-specific nanomaterials can penetrate into the tumor bed 
away from the tumor blood vessels after the PIT treatment. However, little is known 
about how the tumor vasculature responds while the perivascular cancer cells are 
destroyed during PIT. Will the lumen still open for drug delivery? Will the blood 
flow speed increase or decrease due to dramatic change of interstitial pressure? In this 
study, we used intra-vital optical coherence tomography (OCT) to monitor tumor 







1.2 Background  
1.2.1 Intracranial hemorrhage 
Cerebral Hemorrhage is one of the leading complications of needle-based 
stereotactic neurosurgery. Severe hemorrhage requires immediate surgical evacuation; 
otherwise increased intracranial pressure will lead to coma and death. Even with 
emergency treatments, however, patients may still suffer from neurological deficit or 
paralysis. The overall hemorrhage rates of stereotactic brain biopsy is as high as 
59.8% and the risk of symptomatic hemorrhage is 8.8% [19]. Biopsy of deep seated 
lesion (basal ganglion and thalamus) is associated with 2-fold higher hemorrhage risk 
than other regions [20]. One study reported that three in twelve cases of biopsy in 
basal ganglion and thalamus developed the hematoma requiring surgical removal and 
two of these three patients resulted in permanent hemiparesis [21]. On the other hand, 
hemorrhage is also one of the most worried complications of deep brain stimulation 
(DBS) surgery. DBS is a surgical approach for managing certain neurologic and 
psychiatric disorders [22, 23] by implanting therapeutic electrodes to deep brain 
targets. The most widely accepted condition is Parkinson’s disease (PD) [24, 25]. The 
symptomatic hemorrhage rate associated with the insertion of sharp electrodes is 2-
5% [26-31] and 2- to 8-fold higher for hypertensive patients [26, 29, 31]. The sever 
consequence includes permanent paralysis and death [8, 9, 11]. The major problem is 
that operators do not have real-time imaging feedback of the vessels lying ahead of 
advancing needles. Therefore, there is a critical need to detect the at-risk vessels 




1.2.2 Stereotactic discrepancy 
Despite with the preoperative CT or MRI guidance, loss of cerebrospinal fluid 
once the cranium is open, inaccuracy of imaging navigation and brain shift due to 
positioning can lead to marked discrepancies in stereotactic coordinate up to 1 cm 
[32]. In the surgery targeting the deep brain nuclei in size of few mm to cm, the offset 
could result in failed surgery. In DBS surgery, for example, considering how close 
critical pathways travel next to each other in these nuclei, it is not surprising that even 
mm shift of the electrodes can introduce unwanted side effects, such as muscle 
twitching, unpleasant sensation and acute depression [33]. Also, along with the 
development of gene or cell therapies for neurological disorders, precise delivery of 
therapeutic agents into a specific brain region becomes more and more important. For 
example, in the glial-cell derived neurotrophic factor (GDNF) trials for PD (34 
patients), misplaced infusion catheters led to severe adverse events and required 
surgical repositioning in two patients and complete removal in another [12]. Currently, 
microelectrode recording (MER) is gold standard for compensating the stereotactic 
discrepancy. Deep brain nuclei are typically identified by their characteristic neural 
firing patterns [34].  However, refinement mapping comes at cost. Inserting the 
electrode for mapping in one track requires up to 2 hours and typically 3 or more 
tracks are necessary to locate the target. Therefore, guiding therapeutic instrument 
efficiently and accurately to the target is still an unmet challenging.  
1.2.3 Connectomic neurosurgery 
Connectomic neurosurgery that directly targets white matter tracts connecting 




There is growing evidence that abnormal connectivity between these hubs could lead 
to pathological brain states [35-37]. For example, one study has demonstrated 
increased connectivity between cortex and subthalamic nucleus (STN) plays an 
important role in the generation of Parkinsonian symptoms [35]. De-synchronization 
of these mis-wired circuits by electrical stimulation could restore the abnormal brain 
function [38]. However, there is no effective intra-operative guidance tool to locate 
these tracts. MER cannot acquire signal from the fiber tracts. Deviation from the 
tractographically defined target, such as dentatorubrothalamic (DRT) tract can lead to 
poor tremor control, as shown in a patient with bilateral DBS for essential tremor [15]. 
In theory, diffusion tensor imaging provided by MRI can locate these fiber tracts, but 
in reality, intra-operative MRI tractography still suffers from poor signal to noise 
ratio, large voxel size and fiber orientation ambiguity at crossing points [15]. 
Therefore, there is critical need to develop intra-operative guidance tools that can 
specifically target these pathologically-related tracts and it is also important to 
develop better imaging technology for studying the connectome in the micro-scale. 
1.2.4 PIT and SUPR effect 
Photo-immunotherapy (PIT) is an emerging low-side-effect cancer therapy based 
on monoclonal antibody (mAb) conjugated with a near-infrared (NIR) phthalocyanine 
dye (IR700) that induces selective cancer cell  necrosis after exposure to near infrared 
light [39]. PIT induces much less side effect than other anti-cancer therapies due to 
the targeting capability.  Unlike radio ablation, which damages all the tissue close to 
the energy source, PIT only destroys the cells conjugated with mAb and received NIR 




PIT conjugates that receive NIR photons in light illumination path, but do not bind 
with cell membrane receptors, are not toxic for the cells. This is a distinctive feature 
compared with conventional photodynamic therapy and external X-ray therapy, 
which both damage the tissues in the illumination path.  Compared with the radio 
immunotherapy, PIT offers an advantage of only affecting the region received 
photons. PIT does not damage the organs that have high accumulation of the drug but 
have no NIR exposure. 
When exposed to near-infrared light, the PIT conjugate induces highly selective 
cancer cell death while leaving most of tumor blood vessels unharmed and leads to an 
effect termed super-enhanced permeability and retention (SUPR). PIT treatment 
destroying the perivascular barrier without damaging the transportation vessels 
significantly enhances the accumulation of non-specific nanomaterials in the tumor 
bed  and significantly improves the efficacy of nano-anti-cancer drug [18]. Histology 
and ex vivo fluorescence images show that high concentration of non-specific 
nanomaterials can penetrate into the tumor bed away from the tumor blood vessels 
after the PIT treatment [18].  
1.3 Emerging tools for neurosurgery and cancer research 
1.3.1 OCT for neurosurgery 
OCT is an elegant solution to address the challenges in stereotactic neurosurgery: 
targeting brain nuclei [40] , avoiding hemorrhage [41], and locating tractographically 
defined fibers [42]. Dr. Tang’s group inserted a side-viewing OCT probe into human 




structural information provided clear landmarks for determining the probe location.   
Operators can easily know whether the probe has reached or passed GPi by the 
surrounding landmarks, including white matter lamina and internal capsule. The same 
group also demonstrated the structural OCT imaging can guide drug delivery or tissue 
dissection aiming at specific deep brain targets in small rodents in vivo [43]. On the 
other hand, optical microangiography (OMAG) provides sensitive and high resolution 
brain blood vessel imaging [44]. Furthermore, polarization-sensitive OCT (PSOCT) 
allows the white matter track to be isolated from gray matter based on the 
birefringence contrast and PSOCT can also measure the orientation of fiber tracks 
[42]. Therefore, an OCT system that possesses three imaging protocols — structure, 
Doppler, and polarization is a promising tool for neurosurgery guidance. 
1.3.2 OCT for cancer research 
OCT is an emerging biomedical imaging tool, which provides depth-resolved 
images similar to ultrasound images. However, OCT sends light waves instead of 
sound waves into tissue and thus has much better resolution (~ 0.01 mm) than 
ultrasound (~ 1 mm). OCT can provide 3D high resolution image of tumor 
microarchitecture, angiography, lymphangiography and viability [45]. It has been 
widely used in cancer research to study both cellular and vascular response to cancer 
therapy. For instance, Doppler OCT (DOCT) has been used to monitor vascular 
changes caused by photodynamic therapy [46]. However, it remains challenging to 
obtain in situ information without window chamber due to motion artifact. In this 
study, we overcome this challenge by real-time motion gating using speckle variance 




automatically quantify the size of open lumen and the blood flow speed. With the 
novel imaging algorithms, we can obtain the important in situ information from tumor 




Using fiber-optics and micro-optics components, OCT can be readily integrated 
with a wide range of imaging devices such as endoscope, laparoscope, catheter, and 
needle which enable imaging inside the body [47]. Detailed methods of various 
endoscopic OCT design have been introduced in previous review papers [48, 49]. 
Depending on the clinical applications, endoscopic OCT can be designed to be either 
flexible or rigid. For example, imaging the vascular system and the gastrointestinal 
(GI) tract usually requires the probe to be flexible. For applications involving 
incision-based procedures such as image-guided biopsy, a rigid probe will be desired. 
Endoscopic OCT can be categorized by imaging direction too. Forward-imaging OCT 
probe provides information of the tissue located in front of the probe for image-
guided biopsy or device placement. On the other hand, side-imaging probe provides 
circumferential information from the tissue surrounding the probe. Side-imaging 
devices are uniquely suitable for scanning the lumen of tubular systems (such as the 
vascular system or the GI tract). In this section, we summarize endoscopic OCT 
based on different beam delivery methods and beam scanning mechanisms.  
Most of the current endoscopic OCT devices use a single-mode fiber to deliver 
the light into the tissue and collect the backscattering signals. To form a high-fidelity  
                                                 
1
 The content of this section is reproduced from “C.-P Liang, C. Chen, J. Wierwille, J. Desai, R. 
Gullapalli, R. Mezrich, C.-M. Tang and Y. Chen, “Endoscopic Microscopy Using Optical Coherence 





Fig. 1-1. Proximal actuated OCT imaging devices.  
(A) Circumferential scanning catheter. (B) and (C) corresponding to portions 1 and 2 in (A), 
respectively. (B) Distal tip of the OCT imaging catheter, consisting of a single-mode fiber, a GRIN 
lens, and a microprism. (C) Rotary actuation system. (A)-(C) are from Ref. [50]. (D) Linear actuation 
system, from Ref. [51]. Single mode fiber (SMF). Fiber Coupler (FC). (E) Distal tip of the OCT 
imaging catheter, with an angle-cut ball-lensed fiber replacing the GRIN lens, from Ref. [52] (F) Distal 
tip of the OCT imaging catheter with chromatic aberration correction using a pair of doublets, from 
Ref. [53] (G) Distal tip of the OCT imaging catheter integrating the reference arm optics in the distal 
end of the probe, from Ref. [54]. Beam splitter (BS). Reference mirror (RM). (H) A balloon imaging 
catheter with long working distance, from Ref. [55] (I) Multi-channel parallel imaging probe, from 
Ref. [56] (J) A combined forward- and side-imaging OCT catheter, from Ref. [57] (K) Forward 
imaging using paired angle rotation scanning (PARS) techniques, from Ref. [58]. The figure is 
reprinted from ref [59] with permission. 
image, precise scanning of the illumination spot on the tissue is critical. Depending 
on the actuation mechanisms, endoscopic imaging can be categorized by either 
proximal or distal actuation. Alternatively, light can be delivered through fiber bundle 
or gradient-index (GRIN) rod lens, which can relay beam scanning at the proximal 




1. Single Fiber Delivery and Proximal Actuation: The general endoscope design 
consists of two parts: the optical component for projecting a micron-sized light spot 
onto the tissue and the mechanical component for scanning the spot to form two-
dimensional (2D) or three-dimensional (3D) images. The first endoscopic OCT 
design was reported by Tearney et al. [47, 50] as shown in Fig. 1-1A. They assembled 
a GRIN lens to the end of a single mode fiber to focus the emitted light to a spot and 
attached a prism to deflect the light for side-viewing images (Fig. 1-1B). Rotary 
(circumferential) scanning was achieved by using a motor and a gear system at the 
proximal end of the endoscope (Fig. 1-1C). The outer diameter and working distance 
of this probe were 1.1 mm and 2.5 mm, respectively. Later, a similar optical design 
was incorporated into a 27 gauge (~ 470 m) hypodermic needle by Li et al. [60]. 
Doppler imaging was also demonstrated with the rotary imaging catheter [61]. 
Besides rotation, side-view imaging can be also achieved by linearly scanning the 
proximal end of the catheter. Bouma and Tearney developed a linear-scanning OCT 
endoscope by converting the angular displacement of a galvanometer shaft into linear 
displacement of the OCT catheter (Fig. 1-1D) [51]. Later, a similar actuation system 
was used by Yang et al. for Doppler OCT [62]. Proximal linear actuation can also be 
achieved by using a magnetic actuator [63] or a linear galvanometer [64]. By 
combining the rotary and linear (pull-back) actuations, spiral scans can be performed 
to acquire a 3D cylindrical image [55, 63, 65-68].  
The distal optics can be further simplified or improved. Yang et al. used an angle-
cut, ball-lensed fiber to replace the GRIN lens (Fig. 1-1E) in an interstitial Doppler 




OCT probe [69]. Tumlinson et al. have improved the axial resolution to 3.2 m by 
correcting the chromatic aberration using a pair of doublets (Fig. 1-1F) [53]. The 
same group also integrated a beam splitter to the distal end of the OCT endoscope 
(Fig. 1-1G) [54]. This design avoided the dispersion and polarization mismatch 
between the sample and reference arms and thus improved the axial resolution to 2.4 
m.  
To increase the working distance for imaging organs with larger diameter (such as 
the GI tract), Fu et al. developed a balloon imaging catheter [55] with miniature 
GRIN lenses that reduced the spot size from the fiber diameter (9 m) to 3.5 m and 
provided ~20 m spot at focal point 9 mm away from the probe  (Fig. 1-1H). 
Moreover, the same group used a cylindrical reflective mirror to correct the 
astigmatism caused by the wall of balloon catheter to achieve diffraction-limited, 
high–resolution imaging with long working distance [70]. Balloon catheters have also 
been developed by other groups at the Massachusetts General Hospital [66, 67] and 
Case Western Reserve University for GI tract imaging [68]. 
High NA optics provides improved transverse resolution but suffers from shallow 
imaging depth of field. To overcome this limitation, Yang et al. used an elliptical 
MEMS membrane mirror to dynamically adjust the beam focus along with the 
movement of the reference mirror [71]. Other groups have used electrically controlled 
liquid lens [72] or pneumatically actuated micro-lens [73] to vary the focal plane 
position.  Another approach is parallel imaging utilizing a multi-channel OCT setup 
(Fig. 1-1I) to separate the entire depth of field into independent channels [56]. 




In certain applications, it is desired to have both side-imaging and forward-
imaging capabilities. One recent design enables both forward- and side-imaging using 
one catheter [57]. This design was based on an aspheric micro-lens and a prism with 
the beam being scanned eccentrically (Fig. 1-1J).  
Wu et al. reported forward imaging using paired angle rotation scanning (PARS) 
technique [75]. As shown in Fig. 1-1K, this design used two angle-cut counter-
rotating GRIN lenses to deflect the beam and achieve beam scanning in the forward 
region [58, 75]. Also, a handheld, forward-imaging PARS OCT needle (21 gauge, 
820 m diameter) has been reported for retinal imaging [58]. 
Endoscopic imaging using common-path OCT has been demonstrated by Sharma 
and Kang [76]. One recent design used a conical tip fiber to serve as both imaging 
lens and self-aligning reference plane [77]. Common-path endoscopic imaging has 
the advantage of being insensitive to probe length, wavelengh dispersion, and 
polarization distortions. Therefore, it is very convenient for clinical use [78].  
2. Single Fiber Delivery and Distal Actuation: For proximal actuation, the 
mechanical motion (either rotation or linear motion) is translated along the endoscope, 
which might cause friction in scanning, especially when the endoscope is bent inside 
the body (such as colonoscopy). Distal actuation greatly alleviates this problem by 
moving the device at the distal end. However, it is challenging to design a high-
fidelity scanning device within small diameter. Therefore, in general, distally actuated 
endoscopes have larger diameter than proximally actuated endoscopes. 
Boppart et al. reported a 6.4 mm diameter lead zirconate titanate (PZT) cantilever-




PZT cantilever translated the fiber and GRIN lens assembly together to perform beam 
scanning. Other kinds of actuator also achieved similar scanning. Wang et al. used a 
low-voltage (2 V) electroactive ionic polymer-metal composite (IPMC) cantilever to 
actuate the fiber and GRIN lens to achieve both forward- and side-viewing imaging 
[80]. Low-voltage actuation ensures safety in clinical applications. Munce et al. 
developed an electrostatic, forward-viewing probe by placing the optical fiber and 
lens assembly through a platinum coil in the lumen of a dissipative polymer [81]. 
This probe is packaged at 2.2 mm in diameter, and driven by high voltage (1-3 kV) 
but at low current (~2 A). Furthermore, the ground wire is present in the catheter 
itself, which minimizes the chance of delivering an electric discharge to the tissue. 
Alternatively, beam scanning can be achieved by actuating the fiber tip only and 
relaying the scanning spot onto the tissue through the stationary GRIN lens or 
imaging lens (Fig. 1-2B) [79]. Sergeev et al. reported the first fiber-based, forward-
imaging OCT endoscope with ~2.2 mm in diameter [82]. They used an 
electromechanical unit with < 5V voltage to actuate the fiber tip to perform in vivo 
imaging through the accessory channel of a standard endoscope. Liu et al. used a 
tubular PZT actuator to scan the fiber in front of a stationary GRIN lens (Fig. 1-2C)  
[83]. This 2.4-mm diameter endoscope utilized the resonant scanning to perform 
rapid lateral forward-scanning. Continuous focus tracking has been realized with 
lateral-priority scanning [84], and an ultrahigh transverse resolution of 4 m can be 





Fig. 1-2. Distal actuated OCT imaging devices.  
(A) Piezoelectric (PZT) cantilever-based handheld forward-imaging probe, from Ref. [79] (B) Forward 
imaging by actuating the fiber tip only through the stationary imaging lens, from Ref. [79] (C) A 
tubular PZT actuator to scan the fiber in resonance to perform rapid lateral-priority forward-scanning, 
from Ref. [83] (D) Circumferential imaging using a rotary micromotor, from Ref. [86] (E) Distal beam 
scanning using a one-dimensional microelectromechanics (MEMS) mirror, from Ref. [87] (F) Distal 






To perform circumferential imaging, Tran et al. [89] and Hertz et al. [86] 
integrated a micro-motor at the distal end of an OCT endoscope to rotate the micro-
prism (or rod mirror) for circumferential scanning (Fig. 1-2D). Focus tracking can be 
achieved by varying the separation between the GRIN lens and the rod mirror [86]. 
The diameter of the reported probes were 2.4 mm and 5 mm, respectively. The size of 
the micromotor itself can be a limiting factor for miniaturization. In vivo 3D 
endoscopic OCT imaging of a rabbit esophagus and trachea were achieved by 
combining linear translation with a rotational micromotor [90]. By further 
miniaturizing the endoscope down to 1.5 mm, Su et al. recently demonstrated in vivo 
3D imaging of human airway [91]. 
Pan et al. developed an elliptical handheld arthroscope with the long and short 
axes of 7.5 mm and 3 mm, respectively [92]. They used a scanning mirror at the back 
focal plane of imaging lens to achieve 6 mm linear scan length. Miniaturized mirror 
designs using either microelectromechanical systems (MEMS) or PZT technology 
enables further miniaturization of the endoscope. Pan et al. reported the first MEMS 
mirror with a bimorph thermally actuated contraction hinge (Fig. 1-2E) [87]. This 
forward-viewing probe enabled cross-sectional OCT imaging with 2.9 mm lateral 
scan range. Later, the same group modified the MEMS design to increase the scan 
range to 4.2 mm [93, 94]. In vivo cystoscopic OCT imaging of human bladder has 
been demonstrated using the MEMS-based probe with spectral domain OCT [95].  
Zara et al. also reported an electrostatic MEMS scanning mirror for OCT [96]. This 2 
mm x 2.25 mm mirror was resting on 3 m thick polyimide hinges and tilted by a 




polyimide amplified piezoelectric bimorph scanning mirror for spectral-domain OCT 
imaging [97]. This device used a piezoelectric bimorph actuator to drive 
microfabricated polyimide structures at resonance to achieve video rate imaging of 
25-41 frames/s. Chong et al. reported a novel design of optically driven MEMS 
scanning mirror, which eliminates directly powering up the scanning element and 
minimize the hazardous risks for in vivo imaging [98].    
To acquire 3D OCT images, a two-axis MEMS mirror was developed. Jain et al. 
reported a two-axis electrothermal micromirror with 1 mm
2 
mirror size for OCT 
imaging[99]. 3D OCT imaging using 2D MEMS mirror has subsequently been 
reported by several groups [100-102]. The first OCT endoscope utilizing 2D MEMS 
scanner was demonstrated by Jung et al. using time-domain OCT[103]. The entire 
endoscope had an outer diameter of < 4 mm. Later the same group developed an OCT 
probe with 5.5 mm in diameter using 2D MEMS mirror probe and spectral-domain 
OCT[104]. Aguirre et al. demonstrated a ~5 mm OCT catheter with a 1-mm in 
diameter two-axis scanning MEMS mirror at the distal end (Fig. 1-2F) [88]. This 
mirror was driven by angular vertical comb (AVC) actuators on both inner mirror 
axis and outer orthogonal gimbal axis. Kim et al. reported a two-axis magnetically-
driven MEMS scanning catheter with 2.8 mm in diameter, which was actuated by 
magnetic field with low voltage (1-3 V)[105]. Other designs for two-axis MEMS 
scanning mirror [106] and piezoelectric scanning mirrors [107] have also been 
reported recently for OCT imaging. 
3. Optical Relay of Scanning Beam: Another way of formulating an image is 




scanning beam at the proximal end to the distal end. Boppart et al. demonstrated a 
2.68-mm-in-diameter OCT laparoscope using a 1.5 pitch GRIN rod lens as the relay 
[79]. Later, Xie et al. reported a GRIN-rod-lens-based endoscope using spectral-
domain OCT [108]. They used 1 pitch long GRIN rod lens with different diameters 
(2.7 mm and 4.5 mm, respectively) for both forward- and side-view imaging and have 
successfully acquired images from rabbit lung in vivo. Furthermore, high speed (500 
mm/s) dynamic focusing can be achieved by changing the distance between the scan 
head lens  and the proximal entrance surface of GRIN rod lens [108]. Long dynamic 
focus tracking (0-7.5 mm) can be achieved without moving the endoscope.  
Relaying the image planes through the endoscope can be achieved by using a 
flexible fiber bundle as well. A fiber bundle consists of several tens of thousands 
cores to preserve the spatial relationship between the entrance and the output. In fact, 
flexible fiber bundles have been commonly used in standard white light endoscopy. 
Endoscopic OCT using fiber bundles has been demonstrated by Xie et al. [109]. Later, 
Han et al. also demonstrated a common-path OCT endoscope using fiber bundle 
[110]. Different performances of focusing systems (bulk lens, GRIN lens, and 
microlens array) associated with fiber bundle endoscope have been investigated by 


















































[[60]] 17 6.7 0.08 C P NA 0.4 
[[89]] 13 9.5* 2 C D 1 kHz 2.4 
[[86]] 8 5 variable C D 2 kHz 5 
[[63]] 15 5 0.5 S/CP P ~3 kHz 1.5 
[[51]] 30 9.3 0.7 S P 1.7 kHz NA 
[[62]] NA 13 NA S P 8 kHz 2 
[[64]] 18 16 0.3 S P 14 Hz 
 
2 
[[52]] 26 13 0.35 S P 4.8 kHz 0.9 
[[54]] 10 2.4 0.3 S P 20 kHz 2 
[[53]] 4.4 3.2 0.2 S P 250 Hz 
 
2 
[[74]] < 10 7.4  0.125 
 0.375 








[[65]] 9  5-7 
 
NA CP P 100 
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0.83 
[[55]] 39 12 ~ 9 
 
CP P 12 kHz 1.3 
   
[[70]] 
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[[90]] 20 8 NA CP D&P 20 kHz 2.7 
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[[83]] 
16 25 3.5 F D 2.8 kHz 2.4 
[[82]] 20 10* 5-7 F 
 
D 200 Hz 
 
> 2 
[[87]] 20 10 NA F D 2.4 kHz 
 
5 
[[81]] NA 7.4 NA F D 43 kHz 
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[[92]] 17 10 NA F L 2.4 kHz 7.5*3 (oval) 
[[109]] 12 10 NA F FB NA 3.2 





real time displaying speed; &: and; /: or;  NA: Not available; *: Estimated using 
OCT system parameters; C: Circumferential scan; S: Side-imaging linear scan; CP: Circumferential 
with pull back scan; S-2D: Side-viewing two dimensional scan; F: Forward-viewing linear scan; F-2D: 
Forward-viewing 2D scan. P: Proximal actuation; D: Distal actuation; G: Grin Rod Lens; L: Lens; FB: 





Table 1-1 summarizes several key design parameters, such as resolution, working 
distance, image configuration, image formation, speed, and endoscope diameter for 
selected endoscopic OCT devices reported in the literature. In general, the diameters 
for the proximal actuated endoscopic OCT devices are typically smaller than those 
with distal actuation. Overall, endoscopic OCT can achieve micron level image 
resolution, thereby enabling visualization of tissue microstructures in vivo. 
1.3.4 Intra-operative MRI for neurosurgery  
Intra-operative MRI (iMRI), which allows surgeons to address the brain shift 
issue, is gaining popularity and has been applied to many stereotactic neurosurgeries, 
including brain tumor biopsy [113], catheterization [114] and deep brain stimulation 
[115].  Beside the excellent soft tissue discrimination and 3D visualization, high field 
(> 1.5 T) MRI can also perform a wide range of adjunctive imaging protocols, such as 
MR angiography that can potentially reduce the risk of hemorrhage and MR 
tractography that can locate specific white matter (WM) tracts. However, iMRI 
procedures still suffer from low spatial resolution and slow imaging speed. It takes 
several minutes to obtain one high resolution image (~ 1 mm), which cannot resolve 
small targets, such as subthalamic nucleus, for DBS surgery. It is also expensive and 
not ready for widespread use [116]. The MRI compatibility of the surgical tools also 
raises safety concerns. For example, in DBS surgery, the magnetic field may generate 
unwanted ablation and induced stimulation surrounding the electrodes [117]. 
Therefore, developing a cheaper and safer navigation technology with higher 




1.3.5 Transcranial sonography  
Transcranial sonography, which provides real-time intraoperative guidance, has 
started to be used in clinics [118, 119]. Comparing with iMRI, it is cost-effective, 
compatible with conventional surgical tools and provides full access to the patient 
during imaging. Doppler sonography is also available to prevent severe hemorrhage. 
However, depending on the echogenicity of brain structures, sonography may not 
provide direct visualization of targets and surgeons can only infer the location of 
targets from their neighboring structures [119]. The anatomical variability of the 
targets relative to neighboring structures may introduce inaccuracy and need to be 
carefully correlated by other imaging modalities. Also, in DBS surgery, the metallic 
electrodes would introduce echogenic artifact of tip diameter (0.1-1.5mm, depending 
on system parameters), which also need to be calibrated when interpreting the tip 
location [118]. The imaging quality depends on the skull thickness, which limits 
assessment of brain structures in about 10% of elderly whites [120]. Transcranial 
sonography, which provides large FOV and real-time imaging guidance may be a less 
demanding and cheaper alternative to iMRI. However, due to the limitations of 
resolution and contrast, it is necessary to use this technology with other refinement 
technology for precise guidance. 
1.3.6 Optical intra-cerebral measurement 
Near infrared (NIR) optical reflectance is capable of detecting gray/white matter 
transition and thus is useful to localize the gray matter (GM) nuclei surrounded by 
white matter (WM) lamina. The optical signal can be delivered and collected by thin 




microelectrode [121] and an electrical impedance probe[122]. The diffusive NIR 
signal recorded along the trajectories of 200 DBS implantation procedures, shows 
high sensitivity (98% thalamus, 88% STN) and specificity (100% thalamus and 79% 
STN) for brain nuclei detection[121]. However, in the case of inaccurate targeting 
caused by brain shifting, low negative predictive values (50% thalamus and 76% STN) 
reflect the challenge of judging if the target is missed. The NIR signal is also suitable 
for monitoring local blood perfusion and thus has potential to avoid hemorrhage. A 
study showed that laser Doppler perfusion monitoring (LDPM) has higher signal 
when the probe is close to a vessel and it is also capable of detecting pulsatile 
flow[123]. However, the detection of vessels neighboring the probe which are not in 
the direct path of an advancing surgical probe can provide a false-positive when the 
goal is to detect at-risk blood vessels. In fact, the same vessel was detected on both 
advancing and withdrawing process[123]. Therefore, we need to improve the spatial 
resolution of LDPM for rejecting the neighboring vessels and detecting the at-risk 
vessels in front of the advancing surgical tool.  
1.4 Scope of Dissertation 
The major limitation to an efficient, safe and accurate stereotactic neurosurgery is 
the lack of high-resolution and real-time imaging feedback in front of the advancing 
instruments. High resolution imaging feedback that is capable of detecting micro-
landmarks is especially important for localizing mm or sub-mm brain targets. 
Furthermore, real-time feedback is necessary to avoid damaging at-risk blood vessels 




Microelectrode recording (MER, section 1.2.2) is the current gold standard for 
locating deep brain targets, but it only provides feedback from brain nuclei and thus 
cannot be used to prevent hemorrhage or locate neural fiber tracks. Moreover, the 
mapping process usually takes several hours. On the other hand, intra-operative MRI 
(iMRI, section 1.3.4) imaging is gaining popularity for neurosurgery due to its great 
soft tissue contrast and volumetric 3D visualization. However, long exposure time 
(tens of minutes) and millimeter resolution make it difficult to use iMRI for real-time, 
high precision guidance. 
Optical coherence interferometry in combination with miniature optical 
components has great potential for real-time and high-resolution guidance and only 
optical guidance can fulfill these two criteria simultaneously. Other imaging 
modalities, such as ultrasound, MRI or CT, do not have sufficient spatial and 
temporal resolution to overcome these challenges. Due to short optical wavelength 
(around 1 m), the resolution (linearly proportional to the wavelength) of optical 
imaging can easily reach sub- 100 m (~ 10 m). Moreover, real-time imaging is 
achievable due to the ultra-short response time of optoelectonics detectors (~ns). 
However, one major barrier of using scattering based optical imaging is that signals 
from different depths are overlaid preventing imaging beyond superficial surface. The 
development of optical coherence tomography [124] using optical coherence 
interferometry solves this problem (please see details in chapter 2.1). By combining 
reference and sample arm signals, information from different depths can be resolved. 
With depth-resolved, micron-level and real-time imaging capabilities, OCT is used in 




screening. Besides imaging, optical coherence interferometry can also be used as a 
sensor, which provides feedback from flowing blood cells. A simple optical sensor 
provides better cost to benefit ratio in some medical conditions. For example, if only 
the presence of an artery directly in front of the instrument needs to be detected, and 
the size of the vessel is unimportant, the sensor which has much smaller size (0.1 mm 
vs 1 mm) and lower system cost (3000 vs 30,000 USD) will be a better option 
compared to imaging optics.   
In this dissertation, three optical intra-operative guidance tools which provide 
real-time and high-resolution feedback are developed for neurosurgery. These three 
translational devices include one transformative device and two complementary 
technologies for improving the current systems, iMRI and MER.  
In chapter 3, development of a transformative OCT imaging device for 
neurosurgery guidance is described. The forwarding-imaging needle-type OCT probe 
that is capable of detecting micro-landmarks and Doppler flow in front of the needle 
in real time is a promising translational device for neurosurgery guidance. The 
feasibility studies and the performance tests have been performed on in vivo large 
animals. 
In chapter 4, the integration of OCT imaging and iMRI is discussed. The 
combination of high-resolution and real-time optical imaging with MRI improves the 
accuracy of iMRI procedures by two orders (from 1mm to 0.01 mm). Moreover, OCT 
provides a different contrast which enhances the detection of MRI-occult tissue 
landmarks. These improvements will facilitate the capabilities of iMRI for high 




In chapter 5, a complimentary fiber sensor is developed to improve the safety of 
MER. MER is the current gold standard for locating deep brain nuclei, but it increases 
the risk of disastrous intracranial hemorrhage (section 1.2.1). The thin (0.125 mm) 
optical fiber sensor that is capable of detecting Doppler flow in front and providing 
real-time audio feedback can be integrated with MER electrodes to avoid hemorrhage. 
The feasibility studies and validation have been performed on in vivo larger animals. 
Besides neurosurgery, real-time, non-labeling and high-resolution imaging is also 
a powerful tool for preclinical animal studies. Versatile OCT imaging protocols are 
designed to extract various physiological parameters simultaneously without injecting 
contrast dye. In chapter 6, we report the results of using OCT, Doppler OCT and 
speckle variance (please see details in chapter 2) simultaneously to monitor 
hemodynamic changes during an anti-cancer therapy, photo-immunotherapy. 
Versatile protocols not only enable measurement of tissue scattering, blood flow and 
vessel lumen size simultaneously, but also reduce motion artifacts.  
Lastly, in chapter 7, the novelty and impact of each device is concluded. The 
limitations of each technology are discussed and the future improvements are 
suggested. Since the devices developed here are platform technologies, other potential 










Chapter 2: Optical coherence interferometry for imaging 
and sensing 
 
Optical coherence interferometry that is capable of resolving sub-surface tissue 
structure and detecting cell motion in real time without contrast agent is gaining 
popularity in biomedical imaging and sensing. In this work, we will use optical 
coherence interferometry for surgical guidance and intra-vital animal imaging. 
Physics principle of optical coherence interferometry is introduced in this chapter. 
2.1 OCT 
Optical Coherence Tomography is an imaging modality capable of providing 
cross-sectional imaging of biology tissue with micrometer resolution in situ and in 
real time. How different OCT systems resolve the information from different depth 
by using the coherence property of light are introduced in this section. 
2.1.1 Michelson Interferometer 
It is important study Michelson interferometry with a monochromatic light source 
before we discuss OCT systems. Fig. 2-1 shows the schematic of a Michelson 
interferometer. When the monochromatic light reaches the beam splitter, some 
photons will travel to the reference arm and others will travel to the sample. The back 
scattering light from the sample    and the reflected light from the reference mirror 
   will be recombined on the detector.    and    can be expressed in phasor form 
such that: 
       
  (       )           




Here k is angular wavenumber and the factor of 2 arises due to the roundtrip 
propagation.     and    represent the optical path length of sample arm and reference 
arm respectively.   is the angular frequency.  
 
 
Fig. 2-1. Michelson Interferometry 
The detector current    is linearly proportional to the energy density contributed 
from bother sample and reference arm: 
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The first two terms are DC terms, which represent the power reflected back from 
the reference arm and sample arm respectively. The Last term is an interference AC 
term and its intensity depends on the optical path length difference between two arms. 
The interference current reaches its maximum (constructive interference) if the path 




minimum (destructive interference) if the path length difference is equal to the integer 
number of half wavelength. 
2.1.2 Time domain OCT   
The basic structure of time domain OCT (TD-OCT) is a Michelson interferometer 
with a broad band (low coherence) light source (Fig. 2-2). With a monochromatic 
light source, the electromagnetic (EM) waves from two arms can interfere with each 
other no matter how big is the path length difference. However, EM waves can only 
interfere with each other within a very short range with a broad band light source. The 
signal from other region will be rejected (coherence gating) [125]. Therefore, we can 
obtain a depth-resolved tomography by scanning the reference mirror. In this section, 
we will discuss how a broadband light source provides the sectioning capability. 
With a broad band light source,    and    will contain multiple frequency 
components and can be expressed as: 
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And the AC term of the detector current becomes: 
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Because the detector response time (10
-6
s) is much longer than the period of EM 
wave oscillation (10
-14 
s), collecting data from a detector is equal to integrate the 
above equation over time: 
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Since ∫    (   
 )       (    ), we can simplify the above equation to: 
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If we assume the power spectrum form the sample and reference are equal to a 
fraction of source power spectrum  ( )    
  ( )
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Substituting above equations to the interference AC signal results in: 
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If power spectrum   ( )
  is a rectangular function (Fig. 2-2B): 
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The interference AC signal will be: 
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. The equation above shows that the AC term of detection 
current is equivalent to the Fourier transform of the source power spectrum  ( ) and 
is equal to:  
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Since                   the total energy (Fig. 2-2B),   , the equation can be 
rewritten as: 
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Fig. 2-2. Time domain OCT  
(A) Time domain OCT System. From ref [59] with permission. (B) Power spectrum of light source. 





This equation shows that the interference fringe will decay when   (linear 
proportion to path length difference,        ) is away from zero (Fig. 2-2C). In 
other words, the back scattering signal from the sample that has big optical path 
length difference relative to the reference arm will be rejected. The equation above 
agrees with the equation reported in literature [126]. We can estimate the axial 
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The estimated axial resolution is equal to 
   
   
 . Broader spectrum band width 
provides better axial resolution.  
Fig. 2-2A shows the schematic of time domain OCT system. It contains a low 
coherence light source (Fig. 2-2B) and a Michelson interferometry. The reference 
mirror is mechanically scanned back and forth, and the interference signal is 
measured by a photodiode detector. Optical interference between the light from the 
sample and reference mirror occurs only when the optical distances between sample 
and reference paths within the coherence length 
   
   
 (Fig. 2-2C). Sample signals from 
other regions are rejected.  By translating the reference mirror, the axial profile of 
sample’s reflectivity can be generated. If power spectrum is a Gaussian function, the 
axial resolution will be 
       
   




                   , the axial resolution will be 7.6 m. This resolution is 
higher than conventional ultrasound, MRI and CT imaging.  
2.1.3 Fourier domain OCT   
Besides TD-OCT, there is another type of OCT system, Fourier-domain OCT 
(FD-OCT), which has better sensitivity and faster imaging speed [127-129]. In FD- 
OCT, the reference path is kept at one fixed distance and the spectrum of the 
interference signal is acquired. The axial profile is generated by Fourier 
transformation of the interference fringe in k space. FD-OCT imaging can be 
performed in two ways, typically referred to as “swept-source OCT (SS-OCT)” and 
“spectral-domain OCT (SD-OCT).”  
Fig. 2-3 shows a SS-OCT system. It consists of a wavelength-swept light source 
and a Michelson interferometer. From section 2.1.1, we know that the detector current 
   is equal to:  
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This equation shows that the interference term of   is a cosine function of 
wavenumber   and   
  
 
 (Fig. 2-3B & C). Since wavelength swept light source 
generates an EM wave with a specific wavenumber at a time, recording the detector 
current in time is equal to record the current in    space (Fig. 2-3B & C). Fig. 2-3B 
and C shows that the interval between two peaks of detector current in   space is 




difference is small, the frequency of interference fringe in   space will be low (Fig. 2-
3B). 
 
Fig. 2-3. SS-OCT system  
(A) Schematic of a SS-OCT system. From ref [59] with permission. (B) Interference fringe from a 




On the other hand, if the sample back scattering signal is from a deep axial 
position (large path length difference), the frequency of detector current in   space 
will be high (Fig. 2-3C). Therefore, a depth profile of the sample can be obtained by 
performing Fourier transformation of detector current in   space (in time).  
 
Fig. 2-4. Interference fringes of SS-OCT system. 
(A) Measured interference fringe from two locations: red line form a shallower position and blue line 
from a deeper position. (B) Fourier transformation of the interference fringes. Black arrows indicate 





Fig. 2-4A shows measured interference fringes. The red line is from a reflective 
surface at shallower axial position and blue line is from a deeper position. As 
discussed above, the red line has lower frequency than the blue line. The location of 
reflective surface can be easily identified after Fourier transformation (Fig. 2-4B, 
black arrows). This measurement can also be used to quantify the pixel size and the 
axial resolution. If the distance (1.25 mm) and the number of pixels (216 pixels) 
between reflective interfaces are known, the pixel size can be calculated (5.8 m per 
pixel). Furthermore, the axial resolution can also be measured by calculating number 
of pixels between 3dB decay points from the peak. The 3dB width in our 
measurement is two pixels and thus the axial resolution is 11.6 m. 
 
Fig. 2-5. SD-OCT system. 
From ref [59] with permission. 
Similar to SS-OCT system, SDOCT system resolves the depth information by 
Fourier transformation of interference fringe in   space (Fig. 2-3B & C). However, 




system consists of a broad band light source and a spectrometer for detection (Fig. 2-
5). Unlike SS-OCT system, which separates wavenumbers in time, the broad band 
light source sends EM waves with different wavenumber all together into the system, 
and then the information corresponding to different wavenumber   are diffracted by a 
grating to different spatial location and then recorded by an array CCD. The 
interference spectrum in   space is translated into spatial space in SD-OCT system.  
Then, Fourier transformation of the interference spectrum will give us the depth-
resolved sample profile. 
2.1.4  FD-OCT vs. TD-OCT   
FD-OCT has two advantages over TD-OCT: faster imaging speed and superior 
sensitivity. Each axial pixel in TD-OCT is acquired only at the time when the 
reference mirror scans through the equidistant point in the reference arm, but in FD-
OCT, all axial pixels are acquired at the same time with a static reference mirror. 
Therefore, FD-OCT has 10-100 fold increase in imaging speed compared to TD-OCT. 
In this section, we will calculate and compare the sensitivity of TD-OCT and FD-
OCT to demonstrate that FDOCT is intrinsically more sensitive than TD-OCT. From 
the discussion in section 2.1.2, we can derive the total detected power,   , in TD-OCT 
system: 
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If total scanning range of reference mirror is    and total scan time duration is  , 
TD-OCT system will spend a duration of  
  
  
  (   is the coherence length of the light 




interference photons collected from this interface when the reference mirror is at 
equidistance point (   ) will be:  
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where   is quantum efficiency of the detector and    is quantum energy of a 
single photon. The shot noise is given by the square root of the total photon counts 
that are detected during that time duration. Since the total power   is dominated by 
the reference power   , the noise of TD-OCT is: 
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Thus, the signal to noise ratio of TD-OCT [126] is: 
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On the other hand, the detected power of FD-OCT system corresponding to a 
specific wavenumber is  
  ( )    ( )    ( )   √  ( )  ( )     (   (     )) 
In the following context, we will just discuss the SD-OCT system for simplicity. 
If we integrate the detected power over wavenumber in SD-OCT, we will obtain the 
total detected power same as in the TD-OCT system: 








This is not surprising; because the only major difference between SD-OCT 
system and TD-OCT system is the detection system. The detection system in SD-
OCT diffracts the energy corresponding to different wavenumbers into different CCD 
pixels. Therefore, the integration over wavenumbers yields the same result. However, 
the exposure time in two system that contributes to the signal photon count are very 
different. In time domain system, the signal from a given sample interface is collected 
within the duration (
  
  
 )  while the reference mirror is at an equidistance point. In 
SD-OCT system, however, the signal is collected within the entire scan time duration 
(T). Therefore, we get: 








Subsequently, we obtain a SNR measure of SD-OCT [126]: 
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In the case that     is 2 mm and    is 10 m, we will get: 




A SD-OCT system is intrinsically more sensitive than a TD-OCT system (> 23 
dB). This improvement is attributable to the fact that SD-OCT is capable of collecting 
information from all depth during the entire acquisition time.  
2.2 Laser Doppler flowmetry 
Besides structural information, optical coherence interferometry can also be used 
to obtain functional blood flow information. Fig. 2-6A shows the basic principle of 
Laser Doppler flowmetry (LDF). The light source generates photons with long 
coherence length, which means two photons can interfere with each other after 
travelling long separation distance. The coherence length    is inversely proportional 
to the wavelength bandwidth of light source    :  






   
 
If        nm and          , the coherence length    will be 1.69 mm. If the 
separation between two light sources is not over 1.69 mm, EM waves can interfere 
with each other. When the photons reach the biology sample, some will interact with 
static tissues and bounce back into the system with no shift on the frequency (Non 
Doppler-shifted photons). On the other hand, some will interact with moving blood 
cells and have higher or lower frequency shift after the interaction (Doppler shifted-
photons). If we recombine the Doppler-shifted with non-shifted photons on the 
detector, an interference fringe with the frequency proportional to the moving speed 
of blood cells will be generated. Fig. 2-6D models the interference between shifted 




    
Fig. 2-6. Principle of Laser Doppler flowmetry. 
(A) Principle of Laser Doppler flowmetry. (B) Non-shifted EM wave. (C) Frequency shifted EM wave. 
(D) Interference of Doppler-shifted and non-shifted EM waves. The green envelope illustrates the slow 
frequency component. 
Fig. 2-6B shows a non-shifted EM wave (frequency   ). Fig. 2-6C shows a 
Doppler shifted EM wave with higher frequency,      . Fig. 2-6D shows the result 
of combing two signals. The interference signal has two frequency components: 














Since    of a conventional laser (wavelength between 400-1500 nm) is too fast 
(3*10
14
 Hz for 1 m wavelegth) to be measured by an optoelectronic detector, the 
only detectable signal is the slow signal (the green envelope). The detector current is 
linear proportional to the square of the interference signal (Fig. 2-6D) and thus the 




      
  
 
    
   
 
 
  is the effective moving speed parallel to the illumination direction and   is the 
wavelength of light source. In conclusion, LDF sends coherent photons into tissues 
and then recombine the Doppler shifted photons with non-shifted photons on the 
detector. On the detector, an interference fringe is recorded. The envelope of 
interference fringe is linear proportional to the moving speed of scattering particles 
(shown in the above equation).  If we plug in numbers into the equation above: 
       mm/s for normal blood flow speed and     m, the frequency of the 
interference fringe    will be 2-20 KHz, which is in human audible range. In other 
words, we can send this signal to a speaker and interpret the blood flow speed by the 
frequency of the audio feedback.  
2.3 Doppler OCT 
Doppler OCT that allow measurement of blood flow speed at each location is an 
important OCT imaging protocol. Doppler OCT first began with the development of 
TD-OCT. Then, development of Fourier domain OCT (FD-OCT) significantly 
improves the sensitivity and imaging speed of Doppler OCT. In the following 
sections, we will introduce Doppler OCT for both TD-OCT and FD-OCT. 
2.3.1 Time-domain Doppler OCT 
In section 2.1.2, we derive the detector current in a TD-OCT system: 








The axial resolution is inversely proportional to the wavelength bandwidth and 
the photons can only interference with each other if the separation of signal source is 
within coherence range  
   
   
 . In section 2.1.2, we only consider the interference 
between sample and reference arm and did not consider the interference between 
scatters in the sample and the interference between reference signals. If we consider 
these effects, the detector current    will be: 
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The first term is the interference between reference EM waves. However, due to 
long integration time of the detector, this term is a DC term (doesn’t change with the 
position of the reference mirror) representing the total power reflects from the 
reference mirror. The second term represents the interference between scatters in the 
sample locating at the same axial position (         ). This is also a DC term 
representing the power reflects from the sample. The third term represents 
interference between sample scatters locating at different axial positions (        ). 
This term is a function of          similar to the function depicted in Fig. 2-2C.  If 
         
   
   




particles from the sample are within coherence range, they can interfere with each 
other and generate a homodyne interference (self-interference) term. Self-interference 
could occur at any location within illuminated area and should be removed to obtain 
depth-resolved Doppler tomography. The last term is the heterodyne interference 
term, which we have already discussed in section 2.1.2. Although      is much 
stronger than      due to stronger reference power (this is also called heterodyne 
gain), researcher still used a phase modulator in reference arm to isolate the 
     signal from      in frequency domain for a better signal to noise ratio [130].  
With a phase modulator,      oscillates in time with a modulation frequency     . The 
temporal interference fringe can be represented as        ( ) when the scanning mirror 
is at equidistant point corresponding to sample depth  : 
      ( )        (         ) 
   represents the sample backing scattering signal from an axial position  .    
represents a phase term that depends on path length difference and intrinsic 
backscatter spectrum. If we consider Doppler shift     
  
 
, the above equation can 
be rewritten as: 
      ( )        ( (        )    ) 
On the other hand, the frequency of homodyne signal is     and thus can be easily 
separated from heterodyne signal by a frequency filter. After collecting the temporal 
signal shown above, Fourier transform will be performed to obtain     at the specific 
axial position. We can easily obtain the Doppler shift frequency of each axial pixel by 
translating the reference mirror and subtracting the measured frequency with the 




data collection time window for achieving sufficient frequency (speed) resolution. In 
other words, there is tradeoff between imaging speed and velocity resolution.  
2.3.2 Fourier-domain Doppler OCT 
In FD-OCT, an alternative approach uses phase sensitive Doppler analysis, 
offering advantage of decoupling spatial and speed resolution [131]. The discussion 
in section 2.1.3 shows that the depth profile can be obtained by performing Fourier 
transformation of the interference fringe in   space. The transformation result is a 
complex function  ( )   ( ) with an amplitude  ( ) and a phase term ( ). The phase 
difference between adjacent A-scans (or repetitive A-scans) at same axial position, 
  (   ) is linear proportional to the moving speed at the specific location,  (   ): 
 (   )  
 
    
   (   ) 
  is the central wavelength,   is the refractive index of the sample and T is the 
time interval between two A-scans. Averages of phase difference between repetitive 
A-scans are typically used to reduce noise [131] : 
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Fig. 2-7. Characterization of Doppler OCT using a swept source system.   
 
N is number of repetitive scans. This method requires multiple A- scans at the 
same location to improve the signal to noise ratio. In our studies, spatial averaging 
without sacrificing the imaging speed is used to achieve high quality Doppler imaging. 
According to the Kasai autocorrelation equation [132], the equation above can be 
rewritten as: 
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J and Q are defined as:       ( )   ( ). The subscript m is the index of lateral 




average phase difference from a spatial window of M*N pixels. This methods can 
effective reduce Doppler noise without sacrificing the imaging speed. Appendix A 
shows the Matlab code for implementing this method (This codes is adapted from the 
contribution of our past group member, Dr. Jerry Wierwille). Fig. 2-7A shows the 
DOCT images under different flow speed. The parabolic flow inside the capillary 
vessel is clearly imaged. Fig. 2-7B shows the intensity of Doppler OCT is linearly 
response to the flow speed. It is worth to note that when the flow speed is over 1.23 
mm/s, the phase intensity in the center jumps over     (represented in red color) 
degree. This is a well-known issue for phase sensitive Doppler imaging [133]. When 
the flow speed higher than the limitations corresponding to    phase difference, the 
phase will wrap around and the image will encounter a     disruption. If the phase 
only wrap around once, it can be easily unwrapped by add or subtract     to the phase 
jump (Fig. 2-7A, the “Unwrap” Doppler image).  The Matlab code for unwrapping is 
attached in Appendix B. 
2.4 Speckle variance 
Speckle variance is an alternative method to obtain angiography.  Fig. 2-8A 
shows a conventional OCT structure image of ex vivo mouse muscle tissue with an 
injected blood pool (no bulk flow). Fig. 2-8C-E is the zoom-in images of the blue box 
in Fig. 2-8A at adjacent time points with 0.125 second interval. Fig. 2-8C-E shows 
that the static muscle tissue (indicated by the white arrows) has a fixed speckle 
pattern. In contrast, the blood pool containing free-moving particles has a constantly 






Fig. 2-8. Speckle variance between blood pool and static tissue. 
(A) OCT structure image of ex vivo mouse muscle tissue with an injected blood pool. (B) Speckle 
variance image of Fig. 2-8A. The blood pool has much higher intensity than the static tissue. (C) The 
zoom-in images of the blue box in Fig. 2-8A at adjacent time points. 
 
We can calculate the variance between image frames by [134]: 
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j and k are lateral and depth indices of the images and i denotes the slice index.       
is the average of the same set of pixels. The speckle variance image shown in Fig. 2-
8B demonstrates that speckle variance imaging is capable of isolating the region with 
free moving particles from the static background, even when the scattering intensity 
of two objects are similar. Fig. 2-9A shows the test results of speckle variance (SV) 
imaging under different flow speed. SV intensity is independent of the bulk flow 
speed (Fig. 2-9B, red line). Thus, SV is not suitable for quantifying the speed. 




particles even when the speed is low. Combing SV and Doppler OCT, we can 
quantify both flow speed and the lumen size simultaneously. 
 
Fig. 2-9. Comparison between speckle variance and DOCT 
(A) Cross-sectional DOCT and SV images of a vessel phantom (0.4 mm inner diameter) at various 
flow velocity. (B) Total intensity of DOCT and SV versus flow velocity.  
2.5 Coherence-gated Doppler/LD/DOCT 
Coherence-gated Doppler (CGD) is converted from time domain Doppler OCT 
system. The major differences between CGD (Fig. 2-10A) and DOCT (Fig. 2-10B) 
are indicated by the blue arrows. Firstly, we used a light source with a longer 
coherence length and extended the axial dimension of the detection volume from ~10 
m to 190 m. By covering a larger detection volume, we can acquire ensemble 
information from the ROI and omit the requirement to scan the reference mirror. 
Secondly, we further extended the detection volume by omitting the phase 
modulation, which is commonly used in time-domain DOCT system[133, 135, 136]. 




the self-beating signal (the interference between sample photons). Equation below 
shows more details: 
 
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I is the intensity on the detector; ER is the electric field from reference arm and Es 
is the electric field from sample arm; IR is the reference intensity coming from the 
interference between reference photons; Ihom is the homodyne intensity coming from 
the interference between sample photons (self-beating signal); Ihet is the heterodyne 
intensity coming from the interference between sample and reference photons. 
 
Fig. 2-10. System comparison between CGD/DOCT/LD 
 (A) CGD system (B) Doppler OCT system (C) LDF system. SLD: superluminescent diode, LS: light 
source, BW: wavelength band-width, FC: fiber coupler, C: collimator, M: mirror, PM Phase 
modulator, ADC: analog to digital converter, SM: single-mode fiber, GM, gradient-index fiber, EM: 
emission fiber, RE, receiver fiber. The detection volume of each system is shown in the probe drawing 




Because there is no Doppler shift between reference photons, IR is a DC signal. 
On the other hand, due to the Doppler shift between sample photons and between 
sample and reference photons, Ihom and Ihet are AC signals. In conventional time-
domain OCT systems, due to the phase modulation in reference arm, Ihet signal can be 
separated from the Ihom in frequency domain and Ihet is the Doppler signal coming 
from the tissue within the coherence length surrounding the zero-delay plane. 
Therefore, if we select the heterodyne signal by frequency filtering, we can achieve 
high resolution flow imaging as demonstrated by time domain Doppler OCT system 
[130] . In CGD system, we omit the phase modulation and do not intend to 
distinguish the Ihet and Ihom. Therefore, we receive all the Doppler signals accumulated 
in the illuminate path instead of just collecting the signal surrounding the zero-delay 
plane. In terms of its use for self-beating detection, CGD and LDF systems are similar; 
both collect Doppler signals accumulated along the illumination path. However, CGD 
has better spatial resolution than LDF (Fig. 2-10C) due to the confocal probe design 
and the SLD’s shorter coherence length. Moreover, we can optimize the sensitivity by 
tuning the reference power IR [129]. Lastly, the interference fringe is directly 
converted to an audio signal without frequency demodulation. The frequency of the 
Doppler beating signal is proportional to the blood flow velocity: 2 cos( )Vf 

  . The 
velocity V of blood flow within medium-sized vessels  is 10 mm/s [138]. The 
wavelength of light source λ used in the present study is 1.3 m. The effective angle θ 
between the probe and blood flow varies, depending to the angle of approach, 
numerical aperture of the probe, and degree of multiple scattering within the tissue 




Doppler angle is never exactly 90 degrees, so that flow is detectable even with 
orthogonal orientation between the probe and a medium-sized vessel. The peak 
frequencies of the Doppler signal Δf are typically 0.1 - 15.4 kHz, which is within 
human audible bandwidth. Therefore, expensive data acquisition or any further data 
processing is not required to interpret the signal. We can directly identify the flow 
speed by the pitch of sound and the size of vessel by the volume of sound.  
Except the design shown above (Fig. 2-10A), other variations of CGD design for 
different applications are discussed below: 
 
Fig. 2-11. CGD system without dual balanced detection. 
1) Simple interferometer:   If sensitivity is not an issue, we may not need the dual 
balanced detector. This design (Fig. 2-11) has one less circulator, fiber coupler and 







Fig. 2-12. CGD system with a common path fiber probe. 
 
2) Common path fiber probe: Common path fiber design with partially reflective 
coating at the tip simplifies the system (Fig. 2-12). With an integrated reflector, an 
independent reference arm can be omitted. Eliminating the fine adjustment in 
reference arm makes the maintenance easier. The integrated reflector provides better 
dispersion compensation and better axial resolution.  
 





3) Common path fiber probe with a secondary interferometer: One limitation of 
the common path interferometer design is that axial position of the zero delay plane in 
the sample is fixed. This problem can be solved by implementing a second 
interferometer (The dashed box in Fig. 2-13). The zero delay plane in this design can 
be changed by translating the movable mirror in the interferometer for maximizing 
the sensitivity.  
  
4) Heterodyne and Homodyne isolation: In order to enhance the coherence gated 
effect, we may need to separate the homodyne and heterodyne signal by 
implementing a phase modulator to reference arm. Homodyne signal comes from the 
interference between Doppler-shifted and non-shifted photons from the sample. This 
interference could origin from any place within light illumination path. On the other 
hand, the heterodyne signal comes from the interference between non-shifted 
reference photons and shifted sample photons. This signal only comes from certain 
sample region at equidistant position to the reference mirror. Heterodyne and 
homodyne signals are usually mixed together. For some applications, such as pulp 
vitality test, only the heterodyne signal from the pulp region should be collected and 
signals from surrounding tissues should be rejected. These two signals can be 
separated by introducing a phase modulator to the reference arm. This will shift the 
heterodyne signal to a higher frequency and allow us to separate it from low 
frequency homodyne signal. This technique could potentially improve the specificity 








Although OCT imaging (section 1.3.1) has a great potential to transform 
neurosurgery guidance; it will not be possible to bring these great imaging 
capabilities to the bedside without a translational device.  An effective image 
guidance probe for stereotactic procedures in the brain needs to satisfy three criteria. 
It must have a thin needle-like geometry (O.D. < 1 mm), forward-imaging ability to 
identify tissue landmarks, and the ability to detect blood vessels. Numerous forward-
imaging probes have been developed for OCT [57, 80, 81, 95, 99, 139-149], but their 
distal-end designs (> 1 mm) are too large to fit into the thin guide catheter used for 
stereotactic brain surgery. Dr. Tang’s group proposes a thin needle-type side-viewing 
OCT probe as a means for image guidance in DBS [40]. The probe has demonstrated 
that its resolution (15 m) and sensitivity are sufficient to discern micro-anatomical 
landmarks in ex vivo human brains [40]. An in vivo small rodent study has 
demonstrated that the ability of detecting these landmarks in real time can guide the 
delivery of therapeutic agents or dissection to specific deep brain targets [43]. The 
weakness of this approach is that it cannot provide information on at-risk vessels in 
front of the advancing probe. Another novel design using a paired-angle-rotation 
scanning (PARS) probe [58, 150] achieves forward-imaging needle-based (O.D. = 
820 m) endoscopy by using two counter-rotating gradient-index (GRIN) lenses. Yet 
another group developed an elegant forward-imaging probe by relaying the scanning 
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beam using a long GRIN rod lens, while keeping the endoscope itself stationary. This 
design provides fast dynamic focus tracking, which can perform high quality non-
contact in vivo 3D imaging [151]. Two different dynamic ranges of GRIN rod lenses 
have been reported: 72 dB and 108 dB [152, 153]. In order to optimize the dynamic 
range, 8-deg-beveled glass windows and antireflection coating were applied to reduce 
the reflection from the end surface [151]. Previously reported GRIN-rod-lens-based 
probes are primarily for laryngoscopy or laparoscopy applications with probe sizes 
ranging from 2.7 – 4.58 mm [151-154]. To our knowledge, Doppler capability of the 
probes with O.D. smaller than 1 mm has not yet been demonstrated. This may be due 
to the difficulty of actuating the optics in such limited space. The limitations of 
existing approaches for OCT-guided stereotactic brain procedures motivated us to 
develop a GRIN-rod-lens approach that can satisfy the thin forward-imaging, needle-
type criteria and the optical Doppler imaging criteria. 
In this study, we demonstrated that the GRIN-rod-lens design can be miniaturized 
to a needle-imaging probe (O.D. = 740 m). High-speed (100 frames/s) and high-
sensitivity (>90 dB) OCT imaging was achieved by using this needle probe. The 
stationary GRIN-rod-lens also provides high quality DOCT imaging with 41 dB 
velocity dynamic range (VDR) and ±17 m/s velocity resolution. The effectiveness 
and robustness of the system was demonstrated in studies of sheep brain in vivo and 




3.2 Materials and methods   
 
Fig. 3-1. Schematic and pictures of the handheld OCT device 
(A) Schematic of the handheld OCT system. FC: fiber coupler; PC: polarization controller; C: 
collimator, BD: balanced detector, MZI: Mach-Zehnder interferometer (frequency clocks), DAQ: data 
acquisition board, M: mirror, GSM: galvonometer scanning mirror, O: objective lens, AS: alignment 
stages, GL: GRIN lens needle. (B)  GRIN needle. (C) GRIN needle placed beside a U.S. dime. From 
ref. [41].  
3.2.1 Forward-imaging OCT probe 
Fig. 3-1A shows the schematic of the OCT and handheld needle imaging device. 
The swept-source OCT system previously developed by our group [155-157] utilizes 
a wavelength-swept laser as its light source. Spectrum bandwidth of the laser is 100 
nm centered at 1325 nm (Thorlabs, SL1325-P16). The wavelength-swept frequency is 
16 kHz with 12 mW output power; therefore, for 160 axial lines images, the frame 
rate is equivalent to 100 frames per second. A Mach-Zehnder interferometer (MZI) 
receives 3% of the laser output power and uses it to generate a clock signal with 
uniformly spaced optical frequency to trigger the sampling of the OCT signal in the 
analog-to-digital (A/D) converter. The sample and reference arms of a Michelson 
interferometer receives equal portions of the remaining 97% of the laser power. The 




imaging needle (NSG America, LRL-050-P400) through a low numerical aperture 
(NA) lens. Careful NA matching between GRIN lens (NA 0.084) and coupling lens 
ensures maximum coupling efficiency. The distal end of the GRIN needle receives 
the scanning laser spot from the proximal end and relays the backscattered signal 
back to the interferometer. The diameter of the GRIN lens is 0.5 mm and the outer 
diameter including the stainless steel tubing is 0.74 mm. To reduce the risk of blood 
vessel laceration and mechanical resistance in the tissue, we created a blunt tip by 
attaching a transparent cap to the distal end of the GRIN lens. Fig. 3-1B shows the 
picture of the GRIN needle (GL) and Fig. 3-1C shows the GRIN needle placed beside 
a U.S. dime.  
3.2.2 In vivo sheep brain deep vessel imaging 
All procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Maryland School of Medicine, and animals were 
treated in accordance with the PHS Policy on Humane Care and Use of Laboratory 
Animals, the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals, and the Animal Welfare Act (7 U.S.C. et seq.). The effectiveness of the 
needle probe was evaluated by examining its ability to detect vessels below the 
surface of the parietal lobe of sheep (n=2, male, wt. ~ 100 kg). Anesthesia was 
induced with 5 mg/kg ketamine (IV) and maintained under 1-4% isoflurane in 100% 
oxygen. After the sheep was deeply anesthetized, craniotomy was performed. The 
dura and pia membrane on the surface were carefully removed. Then, the imaging 
needle was inserted at the speed of 0.05 mm/s by a motorized stage. OCT and DOCT 




scans per frame) during the insertion. The velocity variance images were derived by a 
previously described method [133]. The variance signal is a surrogate of flow speed 
with a wider speed measurement range than DOCT signal and thus, less prone to alias 
problem existing in the DOCT images. Intensity threshold and a customized image 
segmentation algorithm were used to remove the noise in the variance images. The 
region of interest (ROI) is set in the area with high DOCT signal to noise ratio (SNR). 
A plot of the averaged variance signal in the ROI against time provides quantification 
of vessel pulsation. In one experiment, the OCT probe approached a vessel that was 
located within a deep sulcus and was held relatively immobile by the pia mater. In a 
second experiment, the OCT probe approached a vessel that was located within the 
brain parenchyma and could move with the brain tissue.   
3.2.3 In vivo rat femoral vessel imaging 
To demonstrate that the needle OCT device can differentiate artery from vein, we 
imaged the femoral vessels of Sprague-Dawley rats (n=4, male, wt. ~ 400 g). 
Anesthetized rats (ketamine 50 mg/kg and xylazine 5 mg/kg, intraperitoneal) in 
supine position had their femoral vessels exposed and placed directly under the 
needle OCT probe. The blood vessel color and relative position to the femoral nerve 
allow visual identification of the artery and vein. The imaging speed of the 
simultaneously acquired OCT and DOCT images was 8 frames per second.   
3.2.4 Ex vivo human brain imaging 
To demonstrate the capability of this needle OCT device to image highly-




landmarks for locating the position of the imaging probe, we chose to image the 
human basal ganglia ex vivo. The basal ganglia is an appropriate region for this 
demonstration because it is the target of DBS for movement disorders [6] and because 
it contains high contrast structures that help in defining the anatomic location. An 
unfixed coronal section containing the basal ganglia was placed on a motorized stage 
and kept moist by phosphate-buffered saline (PBS). The OCT probe was gradually 
inserted into the brain tissues by movement of the stage at a constant speed of 0.45 
mm/s. OCT images were recorded along with the needle insertion at 100 frames/s 
(160 A-scans per frame). We also reconstructed full-track OCT images for correlating 
OCT landmarks with brain structures. The reconstructed OCT images were formed by 
splicing sub-regions from raw OCT images. A band of pixels (0.44 mm width, 0.0045 
mm length) located at 0.2 mm from the distal surface of the GRIN lens was excised 
from each raw OCT images and rejoined to form the reconstructed image along the 
track of insertion passage.  
3.3 Results 
3.3.1 Characterization of forward imaging OCT needle 
The forward-imaging needle probe can resolve microstructure with great 
sensitivity as shown by imaging of a lemon (Fig. 3-2A). The major barrier to optimize 
the sensitivity is the high reflection from both surfaces of the GRIN rod lens. We 
tackled this problem by attaching a high refractive index cap (n=1.56, which is close 
to the refractive index of GRIN lens n=1.61) at the distal end, and using oblique 




quantified by measuring the attenuated reflection from a high reflector (mirror). The 
attenuation from the neutral density filter is 36 dB and the mirror reflection is 54 dB. 
Therefore, our sensitivity is 90 dB. With careful dispersion matching at the reference 
arm by another GRIN-rod lens (with the same specification as the one used in the 
sample arm), the axial resolution was optimized. We characterized the axial 
resolution by measuring a reflective mirror (Fig. 3-2B). The axial resolution defined 
by the full width half maximum (FWHM) of the reflection surface is 17 m in air (or 
12 m in tissue assuming an index of refraction of 1.4). The transverse resolution was 
measured by scanning a laser spot across a sharp edge of a reflective metal line on a 
US Air Force target (Fig. 3-2C). The distance between 10-90% intensity is 13 m. 
The field-of-view (FOV) is limited by the diameter of GRIN rod lens. For a 0.5 mm 
diameter GRIN lens, the FOV is 0.44 mm.  
 
Fig. 3-2. Resolution test of the forward-imaging OCT probe 
(A) An OCT image of lemon acquired by a forward-imaging OCT probe. The scale bar is 0.25 mm. (B) 
The axial intensity plot of a highly reflective mirror. The axial resolution determined by FWHM is 17 
m in air (or 12 m in tissue).  (C) The intensity plot across a sharp edge on a US Air Force target. The 




3.3.2 In vivo sheep brain deep vessel imaging 
The blood vessel DOCT imaging from an anesthetized sheep by the needle probe 
shows the feasibility of vessel detection in vivo. Fig. 3-3 shows OCT and DOCT 
superimposed images at different time points of a vessel as it was detected, monitored, 
and then compressed by the advancing probe. The OCT images in Fig. 3-3 shows that 
the speckle size in the lumen of vessels is much smaller than the speckle size of the 
wall making the boundary of the vessel wall easy to identify. The colormap scale for 
the DOCT signal is analogous to the colormap used for ultrasound Doppler signals. 
Red to yellow represents increasing flow speed in one direction whereas blue to cyan 
represents increasing speed in the opposite direction. However, the alias rings in these 
images do not indicate the change of flow direction. Instead, the abrupt change of 
color represents higher velocity that is “wrapped.” “Wrapping” occurs because the 
velocity exceeds the velocity dynamic range (VDR). When velocities exceed this 
limit in either direction, they “wrap” to values at the other end of colormap [133]. The 
superimposed image further verified the boundary of lumen and indicated that this 
system can provide measurement of the vessel size (~ 0.2 mm in diameter) that is 
verified by both OCT and DOCT. Fig. 3-3A shows a vessel was detected in front of 
the probe. Fig.3-3 shows the probe was approaching the vessel. Fig. 3-3B shows an 
image of the probe that was stopped right before hitting the vessel. Fig. 3-3 shows the 
vessel pulsation while keeping the probe still. The periodic changes observed in the 
flow speed images strongly suggest that the vessel is a pulsating artery. Fig. 3-3C 
shows the needle probe compressing the vessel. Fig.3-3 shows that, with the probe 




Doppler signal also decreases accordingly. Fig. 3-4 shows that the pulsation can be 
quantified by flow velocity variance. Flow velocity variance varies monotonically 
with flow velocity and has a wider measurement range [36]. Therefore, it provides 
more accurate estimation of the flow speed than the aliased DOCT signal. However, 
it is prone to large error in regions with low SNR, so we set our ROI in a region 
having stable DOCT signal (the black rectangle in the variance image). Both DOCT 
and variance images show a dramatic difference between peaks and valleys. The 
larger red signal area in the DOCT images indicates higher flow velocity at the peaks. 
Also, the variance images show stronger signal corresponding to the higher flow 
velocity at peak. The average of the ROI variance signal versus time shows clear 
pulsation pattern. The heart rate is 80 beats per minutes. The high SNR Doppler 
signal enables us not only to detect the vessel but also to monitor the physiological 
change of the blood flow.  
An example of the vessel being pushed aside by the probe is shown in Fig. 3-5. A 
vessel was detected 0.93 mm in front of the probe by its Doppler signal (Fig. 3-5). As 
the probe approached to the vessel, the vessel is gradually pushed aside (Fig. 3-5A&C) 
and finally out of the field of view (Fig. 3-5D). We also notice that the high blood 
flow speed in this large vessel made the Doppler alias rings smaller than the pixel size 
resulting in randomized Doppler signals. Although DOCT cannot provide quantitative 





Fig. 3-3. A high-risk case of contacting a brain vessel.  
Compression of a vessel by the OCT probe. All the images are from the same vessel. The bright line 
on the top of the images is the junction between GRIN rod lens and the transparent cap. The front 
curved surface of cap had direct contact with the tissue. The scale bar in all the figures is 0.25 mm. (A) 
The OCT/DOCT superimposed image shows a vessel 0.65 mm in front of the probe. (B)  The 
superimposed image from shows a vessel right in front of the probe (C) The superimposed image from 
shows the vessel was compressed by the probe. From ref. [41].  
 
Fig. 3-4. Quantification of pulsation by flow velocity variance.  
The first row shows Doppler images at different time points specified in the second row. The third row 
shows the corresponding velocity variance images. The black rectangle shows the ROI. The value of 
flow velocity variance in the plot is the average value of ROI. The dashed lines indicate the time points 





Fig. 3-5.  A low-risk case of contacting a brain vessel.  
The images from A-D are in sequence as the probe was advancing. The scale bar in the figure is 0.25 
mm. The OCT/DOCT superimposed image of a vessel (A) 0.75 mm in front of the probe, (B) 0.35 mm 
in front of the probe with the vessel was being pushed aside, (C) 0.35 mm in front of the probe with the 
vessel was pushed further away from the probe, and (D) after the probe had passed the vessel. From 
ref. [41].  
3.3.3 In vivo rat femoral vessel imaging  
Imaging the rat femoral vessels shows the feasibility of vessel type differentiation 
by the OCT needle probe. The color and appearance of the rat femoral artery and vein 
distinguish them unequivocally by visual inspection. Fig. 3-6A and 3-6B show both 
OCT and OCT/DOCT superimposed images of a rat femoral artery. Fig 3-6C and 3-
6D are the images of the femoral vein. The bright lines at the top of images represent 
the end surface of the imaging needle. The speckle size and superimposed images 
allow us to differentiate the lumen and the vessel wall easily. The images show that 
the arterial wall is much thicker than the venous wall. Another distinguishing feature 
is the black outline surrounding the arterial lumen shown in Fig. 3-6A. This black 
outline is a muscular medial layer of endothelial lining lacking highly scattering 




elastin and collagen [158]. Therefore, in Fig. 3-6C, we do not find this black layer. 
Furthermore, the steeper flow speed gradient in the artery leads to much denser alias 
rings in Doppler images (Fig. 3-6B vs. 3-6D). Therefore, the wall thickness, black 
inner lining and flow speed are three important parameters for differentiating the 
vessel types. 
 
Fig. 3-6. OCT and OCT/DOCT superimposed images of rat femoral vessels 
The scale bar represents 0.25 mm. (A) OCT image of femoral artery. (B) Superimposed image of 
femoral artery. (C) OCT image of femoral vein. (D) Superimposed image of femoral vein. From ref. 
[41].  
3.3.4 Ex vivo human brain imaging  
The images of the human basal ganglia ex vivo illustrate the potential for 
neurosurgical guidance. Fig. 3-7 shows a camera image of human brain tissue and the 
full-track reconstructed OCT image. In the camera image of brain tissue, note the 
white appearance of fiber tracts surrounding the gray matter nuclei and the striation of 
white fiber bundles within the putamen. The reconstructed OCT track was obtained 
by pushing the probe from right to left 2 mm below and parallel to the surface of the 
brain slice.  This figure illustrates the high degree of contrast between gray and white 




gray matter putamen, and the lamina to the GPe can be clearly identified. These OCT-
detectable structures are useful anatomic landmarks that can be used in stereotactic 
surgery [40, 43, 159]. The structures identified in this passage includes: extreme 
capsule (ex), claustrum (Cl), external capsule (ec), putamen (PUT), lateral medullary 
lamina (lml). The white matter typically has much higher intensity with shallower 
penetration depth. Also, the characteristic white matter striations in the putamen 
display high contrast and can be easily identified. Because the needle was inserted 2 
mm below and parallel to the surface of the brain slice, the number and the size of the 
fiber tracts in the camera image are different from the fiber tracks in OCT image. 
Reconstruction of the full-track OCT image allows better identification of the probe 
location. This information can assist in the guidance of therapeutic tools to deep brain 
targets with micrometer precision.  
 
Fig. 3-7. Full-track OCT image of a human basal ganglia. 
The probe on top of the brain tissue shows relative dimension and the direction of insertion (from top 
right to bottom left). The full-track OCT image is placed proximal to the insertion passage. Major 
structure are labeled: extreme capsule (ex), claustrum (Cl), external capsule (ec), putamen (PUT), 
lateral medullary lamina (lml), globus pallidus externa (GPe) and globus pallidus interna (GPi). The 
width of the reconstructed OCT images in this figure is expanded for better visualization. The real 





An image-guidance probe for stereotactic neurosurgery needs to address multiple 
challenges. The fundamental challenge is to provide information on what is in front of 
the probe in real time for a procedure that is otherwise blind. The primary clinical 
objective is to avoid lacerating blood vessels in front of the advancing probe. A 
secondary objective is to obtain information on the position of the probe tip relative to 
anatomic landmarks. This has to be accomplished with a thin needle-like geometry 
that will fit inside existing stereotactic apparatus. 
The GRIN-rod-lens approach provides a solution to the multiple requirements for 
stereotactic neurosurgery.  By using motion-free GRIN rod lenses as relay optics, the 
high speed A-line scanning rate of the laser system can be fully exploited without 
compromising the needle size. This high speed forward-imaging capability allows us 
to promptly avoid the at-risk vessels (Fig. 3-3) and locate the tip position (Fig. 3-7). 
Moreover,  stable and high speed A-line scanning is critical for optimizing the flow 
VDR [133]. Unstable and slow A-line scanning rates will degrade VDR and hinder 
vessel detection by DOCT.  Our system not only detects vessels but also monitors the 
physiological changes of the blood flow (Fig. 3-4). Since there is no complex 
actuation at the distal end, this probe is one of the thinnest forward-imaging OCT 
probes. The diameter of the probe is a compromise between providing sufficient field 
of view and minimizing tissue injury. A GRIN lens diameter of 0.5 mm and field of 
view of 0.44 mm allows easy recognition of vessels, and the overall diameter of 0.74 
mm is smaller than the inner diameter of existing stereotactic cannulae. Our current 




interfacing the rod lens with the scanning head. Therefore we can insert 9.5 cm deep 
inside the brain. The current probe length is more than adequate to reach all existing 
targets of DBS in the human. It can also be used for brain tumor biopsy, ventricle 
identification, etc. Also, the length could be further extended by splicing several 
pieces of GRIN rods together. 
Evaluating the system in a living large mammalian brain provides correlates to the 
conditions of clinical stereotaxis. While useful information can be obtained from 
studies in phantoms, rodents and ex vivo human tissue, these substitute samples 
cannot provide adequate simulation of the live human brain surgery.  There are no 
vessels in the rat brain that are comparable in size to those in the human brain. Large 
animal brain imaging in vivo also provided an opportunity to determine the extent of 
a potential problem for DOCT. The brain moves in conjunction with respiration and 
heart beat. We found that this was problematic for imaging surface vessels, but not 
for intraparenchymal vessels. The surgeons can bypass surface vessels because they 
can directly visualize them. Once the probe entered the brain parenchyma, the 
movement problem is greatly decreased, possibly because the probe appears to 
stabilize the tissue directly in front of it. Additionally, vessels within the parenchyma 
can be easily pushed to the side by the probe (Fig. 3-5), whereas vessels in deep sulci 
(Fig. 3-3) that are tightly attached to the pia mater are not easily pushed aside by the 
probe. Vessels in sulci are really surface vessels that are buried by the cortical folds. 
This is consistent with anecdotal experience of neurosurgeons who meticulously 




Besides detecting the vessels, the probe can also monitor the pulsation (Fig. 3-4) 
and differentiate the vessel type (Fig. 3-6). These capabilities could be valuable for 
screening the vessels posing high risk in neurosurgery.  We acknowledge that the 
aliasing problem may hinder using DOCT signal to quantify blood flow; however, we 
can work around this problem by using velocity variance [133] or axial Kasai 
algorithm [160]. Also, the high speed Fourier domain mode locking laser should be 
able to increase the velocity detection limit by one to two orders [65, 161].  
In addition to detecting the at-risk vessels, this forward-imaging needle-type OCT 
probe can be an important complementary technology for current stereotaxic 
neurosurgery. Prior studies have demonstrated the ability of catheter-based OCT to 
provide information on the position of the probe relative to neighboring anatomic 
landmarks [40, 43]. Although the forward-scanning probe does not provide as much 
field of view as with the rotating side-imaging approach [40], the needle probe can be 
used to provide real-time feedback on the degree to which the brain has shifted due to 
the surgery induced CSF leak. This is accomplished by establishing the probe tip 
relative to critical landmarks such as a prominent gray matter-white matter junction 
(Fig. 3-7). Since the stereotactic system provides the expected position, any deviation 
between the expected and actual location of a landmark provides the surgeon useful 
information on the degree to which the brain has shifted during surgery. Secondly, it 
can often provide optical signatures of specific anatomic structures (i.e. the pencils of 
fibers in the putamen). The use of image guidance probes in conjunction with pre-
operative MRI or CT images will give the surgeons greater confidence on the probe 




A possible way is to reconstruct a wider FOV image using manual scanning and 
optical tracking [162]. The next phase of this project will be to miniaturize the overall 
proximal size and integrate a functional imaging modality. Besides the application in 
stereotactic procedures, this device can potentially be applied to many other image-
guided interventions and for the detection of blood flow involving difficult to reach 
structures.  
3.5 Conclusion 
The forward-imaging needle-type OCT probe is a promising complementary 
technology for current stereotaxic neurosurgery. With real time OCT/DOCT forward 
imaging capability, it may be possible to avoid laceration of at-risk intraparenchymal 
vessels and infer probe location relative to OCT detectable landmarks. The device 






Chapter 4: Concurrent Magnetic Resonance Imaging (MRI) 




As described in the last chapter, OCT is a great complimentary technology for 
stereotactic neurosurgery, but small field of view (FOV) limits its usage. MRI is the 
most widely used neuroimaging tool with large FOV. Combining high resolution 
OCT with large FOV MRI will allow the neurosurgery being performed more 
efficiently and accurately. The goal of this study is to develop a MRI compatible 
OCT imaging system and validate the multi-scale MRI/OCT imaging for 
neurosurgery guidance.  
The superior tissue contrast and versatile imaging protocols of intra-operative 
MRI (iMRI) make it a promising guidance tool for various surgeries [116, 163, 164]. 
However, sending a patient into the constrictive MRI bore interrupts the surgical 
rhythm and thus the number of imaging studies in one procedure is limited to two or 
three times. On the other hand, the iMRI system with big opening and better 
accessibility to the patient suffers from poor imaging quality. In order to take full 
advantage of MRI guidance, MRI-compatible robotic systems that can operate inside 
the restrictive MRI bore with near real-time MRI guidance have been developed 
[165-167]. These systems are promising, but their targeting capability is still limited 
by the resolution of MRI. Moreover, the artifact surrounding surgical tools (such as 
metallic electrode or biopsy needle) obscures the important region of interest (ROI) 
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and makes it difficult to achieve sub-mm accuracy. In this study, we integrate an OCT 
imaging system to the MRI-compatible robot developed by Dr. Jaydev Desai’s group 
at the University of Maryland[166] and use the microscopic OCT information to 
deliver a biopsy needle with unprecedented accuracy. The innovative MRI-
compatible robot enables us to teleoperate the needle device within the constrictive 
MRI bore and performs OCT under continuous MRI monitoring. The MRI-
compatible robot opens a new possibility of concurrent multi-modal imaging that 
could potentially have huge impact on biomedical imaging. The combination of 
macro-scale MRI morphology and micro-scale OCT architecture in a concurrent and 
co-registered manner paves a new avenue to the iMRI interventions required sub-mm 
precision. 
 
Fig. 4-1. MRI/OCT system 
(A) Picture of the MRI/OCT imaging system. (B) Side-viewing OCT probe consisted of a single-mode 




OCT probe. (D) MRI-compatible titanium needle probe for OCT imaging, with the side-window 
covered by transparent heat shrink tubing (HST). (E) OCT image of a human finger with 
microstructures including stratum corneum (SC), epidermis (E), and dermis (D). From ref. [168]. 
4.2 Materials and methods 
Fig. 4-1A shows the picture of the integrated MRI/OCT imaging system, which 
includes a MRI-compatible robotic device previously invented by our collaborator Dr. 
Jaydev Desai's group [166]. To work within a strong magnetic field (3T MRI, 
SIEMENS), we actuate the robot by a pneumatic cylinder instead of a conventional 
motor. By pressurizing or depressurizing the air chambers in pneumatic cylinder (the 
pressure is controlled by a pneumatic directional control valve (MPYE-5-1, FESTO) 
connected to an air compressor), we can move the needle forward or backward. The 
MRI incompatible pressure control units, including the control valve and the air 
compressor are outside the MRI room and are connected to the robot through long 
plastic tubes. The position of the needle is recorded by an encoder with 12.7 m 
resolution for feedback control. The smallest step size that is achievable by the 
pneumatic robot is 1 mm and the response time for 1 mm displacement is 0.2 second. 
Regarding to the OCT system, the spectrum bandwidth of the swept source OCT laser 
is 100 nm centered at 1325 nm (SL1325-P16, Thorlabs). Therefore the calculated 
axial resolution is 7.7/5.9 m in air/water. The wavelength-swept frequency is 16 kHz 
with 12 mW output power. The OCT system [41] sitting outside the MRI room is 
connected to a side-viewing OCT probe (Imagewire, St. Jude Medical) through an 8-
mm-long single mode fiber. The side-viewing probe consists of a single-mode fiber 
for light transmission, a gradient index (GRIN) multi-mode fiber for light focusing 




0.23 mm) is placed in a 16 gauge (O.D. = 1.7 mm) titanium biopsy needle (Invivo). A 
side window is created on the needle to allow the laser beam from the OCT probe to 
reach the sample and the window is also encapsulated with a transparent heat shrink 
tubing (HST) for preventing tissue collection (Fig. 4-1D). The measured working 
distance from the outer surface of the needle probe is 0.2 mm. The HST deteriorates 
the transverse resolution from 20 m to 30 m and the axial resolution remains 15 
m. The sensitivity drop introduced by the HST is minimized to 1-2 dB by filling the 
needle with water for index matching. The OCT probe is linearly actuated forward 
and backward along the long axis of the needle by an MRI-compatible PZT actuator 
(Bending actuators, Piezo Systems) attached at the proximal end. We only use the 
information from the pull-back direction, because it is difficult to insert a flexible 
fiber linearly from a distal site. Although we only use half of the information, the 
tissue is under oversampling.  With 1mm/s needle insertion speed and 18.3 mm/s 
sampling rate (15 Hz frame rate and 1.22 mm scanning range), the overlap between 
OCT images is 94%. However, oversampling can provide us additional information, 
such as the tissue deformation, elastography and Doppler flow. On the other hand, the 
spiral scanning may be more efficient, but it is also more complex and expensive to 
build an MRI-compatible rotary motor. Instead, if the tissue is relative homogeneous 
in transverse direction, a simple PZT bender that allows us to detect the transition 
between layered structures is sufficient. Fig. 4-1E shows an example OCT image of a 
human finger. The microstructures beneath the skin surface, including stratum 




are also visible as spiraling columns in the SC region. The PZT actuator and the OCT 
needle probe are moved in tandem driven by the pneumatic actuator. 
 
Fig. 4-2. Co-registration of MRI and OCT images using a custom-made phantom.  
(A) Dynamic MRI and (B) high-resolution T2 MRI images of the OCT needle and the plastic sheet 
phantom (indicated by white arrows). The artifacts from sharp edges on the needle tip and the side 
window are indicated by red arrows. (C) Concurrent OCT image of the plastic sheet phantom. OCT 
FOV covers the entire 1 mm thickness of the phantom for co-registration of OCT images with low-
resolution dynamic MRI and high-resolution T2 MRI images. From ref. [168]. 
We use a custom-made phantom to co-register the MRI and OCT images. A 
plastic sheet (thickness = 1 mm) with holes that are large enough for the OCT needle 
to pass through is immersed in a water-filled container. The OCT needle goes through 
a hole on the phantom until the side window lines up with the plastic sheet so that the 
reflection from the plastic sheet is visible in OCT image (Fig. 4-2C). The OCT laser 
beam is pointed downward (i.e., the plane containing the OCT needle central axis and 
OCT beam is normal to the MRI table). In MRI images (Fig. 4-2A & B), the plastic 
sheet (white arrows), the needle and the artifacts from the needle tip and the side 
window (red arrows) are clearly visible. Since the OCT imaging window has been 




corresponding location of the OCT window. Therefore, we can locate the OCT 
window in MRI image and measure the distance from the OCT window to the needle 
tip. Although the encoder can track the needle position with 12.7 m resolution, the 
accuracy of co-registration cannot be better than the resolution of MRI (~ 1mm). It 
may be difficult to achieve sub-mm co-registration, but the targeting precision is only 
limited by how accurate OCT can determine the boundary surrounding the target and 
it is not limited by the resolution of MRI.  
 
Fig. 4-3. Co-registered MRI/OCT images of chicken breast tissues ex vivo.  
(A) High-resolution T2 MRI image with arrows “B”, “C”, “D” indicating the positions of 
corresponding enlarged MRI images shown in (B-D). (E-G) The OCT images corresponding to the 
location “E”, “F”, “G” shown in (B-D). (H) Concurrent dynamic MRI and OCT imaging of chicken 
breast tissue during needle insertion. From ref. [168]. 
4.3 Results and discussion 
In the first study, we demonstrate the multi-scale imaging on the chicken breast 
tissue ex vivo. We place the chicken breast in a wrist coil (SIEMENS) for MRI 




needle insertion to plan the trajectory and after needle insertion to verify the final 
location. Although high-resolution T2 MRI can resolve the millimeter-scale structures 
(Fig. 4-3A), the long image acquisition time (several minutes) makes it impossible for 
real-time guidance. Fig. 4-3B-D show the enlarged MRI images of the area indicated 
in Fig. 4-3A by “B”, “C”, “D”. Fig. 4-3E-G are the corresponding OCT images to the 
area indicated by “E”, “F”, “G” in Fig. 4-3B-D. The correlation between MRI and 
OCT is based on the calibration shown in Fig. 4-2. Fig. 4-3 shows the MRI and OCT 
images extract from the same location. However, due to huge difference on resolution 
and contrast, MRI and OCT images may look very different. At the position “B”, the 
needle is in a homogeneous muscle tissue and its corresponding OCT image (Fig. 4-
3E) also shows similar feature. At the position “C”, the needle is very close to a 
fibrous connective tissue. The corresponding OCT image (Fig. 4-3F) shows the same 
structure with few finer fibers beneath it. At position “D”, the OCT image reveals fine 
connective tissues within muscular tissues. Fig. 4-3H shows the concurrent dynamic 
MRI and OCT imaging during needle insertion. Low-resolution dynamic MRI (1 
frame/s) provides the general needle location and the real-time OCT (15 frames/s) 
reveals the microstructures surrounding the needle.  Therefore, the operator can 
estimate in real-time the distance to the target from the dynamic MRI image and 
decide whether the needle reaches the target based on the OCT tissue architecture. 
The nonlinear motion is obvious while the needle was being inserted into the chicken 
breast and it affects the uniformity of some OCT images. The encoder cannot correct 
the distortion caused by the deformation of the needle or the tissue. Therefore, the 




A-lines directly from the OCT image and correct the imaging distortion should be 
integrated with the future system to improve the uniformity. 
 
Fig. 4-4. Co-registered MRI/OCT images of human basal ganglia ex vivo.  
(A) Photo of the human brain tissue containing basal ganglia. Different tissues types are visible, 
including white matter lamina (WL), putamen (PUT), internal capsule (IC), and thalamus. The OCT 
needle probe is sitting on top of the tissue indicating the insertion track (the actual insertion track is 
beneath the tissue surface). (B) T2 MRI image of the brain slice. (C) Full-tack OCT with co-registered 
lateral position with MRI. The axial dimension is expanded for better visualization. The scale bar for 
the axial dimension is 0. 5mm.  (D) Plot of normalized MRI intensity (green), normalized OCT 
backscattering intensity (blue) and normalized OCT attenuation coefficient. (E) Concurrent dynamic 
MRI and OCT imaging of human brain tissue during needle insertion. (F) The attenuation coefficient 
of GM (PUT), GM/WM mixture (thalamus) and WM (IC). The p values between data sets are smaller 
than 0.0001. From ref. [168]. 
We image an ex vivo human basal ganglia to validate MRI/OCT for neurosurgery 
guidance. Intra-operative MRI (iMRI), which provides large FOV and direct 
visualization of brain targets in operation, has been applied to stereotactic 
neurosurgery, including brain tumor biopsy [113], catheterization [114] and deep 
brain stimulation [115, 164].  However, the resolution and the contrast of MRI are not 




researchers have used OCT to locate these nuclei in hurman brain ex vivo [40] and in 
rat brain in vivo [43] . We place a slab of frozen human brain tissue containing basal 
ganglia in a gelatin holder filled with saline at room temperature and wait until it is 
completely thawed. Then, we acquire a few pre-operative T2 images (4 minutes per 
frame) to plan the trajectory. We monitor the advancement of the needle by the 
dynamic MRI (1 frame/s) and OCT imaging (15 frames/s) in real time (Fig. 4-4E). 
We can easily identify the boundary between the gray matter (GM, low intensity with 
deep penetration) and the white matter (WM, high intensity with shallow penetration) 
while most of structures are occult in the dynamic MRI (Fig. 4-4E). Fig. 4-4A shows 
a picture of a brain tissue. In the high-resolution MRI image (Fig. 4-4B), the 
transitions between the GM nucleus, putamen (PUT, white on T2 image) and its 
surrounding WM bundles, white matter lamina (WL) and internal capsule (IL) (dark 
on T2 image) are clearly visible. We reconstruct a full-track OCT image (Fig. 4-4C) 
from the OCT video and correlate it with the large-scale MRI morphology. From each 
frame of the OCT video, we select a band of A-lines with 66.67 m width (1mm/s 
sampling rate, same as the needle insertion speed) from the same location. Then, we 
stitch these bands together to form Fig. 4-4C. We align the per-operative MRI to the 
intra-operative OCT images by matching them respectively to the dynamic MRI 
images. The accuracy of the alignment is limited by the resolution of dynamic MRI 
images, which is 2 mm. In Fig. 4-4D, we plot the normalized MRI intensity (green 
line), normalized OCT backscattering intensity (blue line) and the normalized 
attenuation coefficient (red line). The normalized OCT attenuation coefficient and 




average filter with 2.35 mm average width. In the full-track OCT image, the 
transitions between PUT and its surrounding WM bundles (WL & IC) are obvious 
and are well correlated with the MRI image. The full-track OCT shows that the GM 
nucleus (PUT) has lower backscattering intensity, deeper penetration depth and thus 
smaller attenuation coefficient (Fig. 4-4D), while myelinated WM tracks have higher 
backscattering intensity, shallower penetration depth and larger attenuation 
coefficient. This result agrees well with previous studies [159]. It is worth note that 
the transition from IC to thalamus is not visible in MRI image. The thalamus is a GM 
nucleus containing uniformly distributed WM fibers. The mixture of WM and GM 
gives it a very low contrast to the surrounding WM tracks in MRI image.  However, 
we can easily identify the boundary between IC and thalamus in OCT image. 
Compared to the PUT, high level of WM in thalamus reduces the optical penetration 
depth and increase the attenuation coefficient (Fig. 4-4D). Also, the backscattering 
intensity from the thalamus is not as high as in the WM bundles. This result agrees 
with a previous study [40]. Fig. 4-4D shows that the transitions between PUT and its 
surrounding tissues are obvious in both imaging modalities, but only OCT provides 
good contrast between IC and thalamus. Fig. 4-4F shows that the attenuation 
coefficient of thalamus (GM /WM mixture) is between IC (WM) and PUT (GM) and 
the difference is statistically significant (p<0.0001). The attenuation numbers in Fig. 
4-4F are calculated from a 1 cm wide unsmoothed data at the location indicated by 
the black arrows in Fig. 4-4D.   This result suggests that OCT can discern the MRI-
occult nuclei in basal ganglia with a different contrast. Contrast in MRI images 




T2, (for example, protons in lipids) will decay faster than protons with longer T2 (For 
example, protons in water) and will appear with lower signal intensity. Therefore, the 
white matter, which consists of densely packed lipid membranes, has lower intensity 
than other tissues in T2 image.  Lipids are also strong optical scatters and give bright 
intensity in OCT image [40, 41, 159]. Densely packed axon fibers in white matter 
region contain high concentration of lipids and thus has strong OCT signal with 
shallow penetration depth. Although the source of the contrast of both imaging 
modalities comes from two different physical phenomena, OCT is able to produce 
images at a very high resolution over a small field of view.  Such high resolution is 
currently not possible with MRI. However, the two techniques can complement each 
other, where MR images provides guidance to an OCT catheter to a specific location 
from where high resolution images could be obtained.  The combination of the two 
technologies enables one to span the resolution scales afforded by each of the 
modalities. 
In conclusion, we develop a multi-scale MRI/OCT imaging system with tele-
operated robot from Dr. Jaydev Desai’s group that has potential to improve the 
accuracy and efficiency of iMRI procedures. Real-time OCT images can fill the gap 
between pre- and post- operative MRI images and thus allow operators to reach the 
target more efficiently. Moreover, high-resolution OCT imaging provides 
microstructural information and different contrast that can be useful for detecting 
MRI-occult tissue landmarks. Therefore, combining large FOV MRI with high-




will include the investigation of the impact of physiological motion (breathing, etc.) 




Chapter 5: Coherence-gated Doppler: a fiber sensor for 




The needle-type forward-imaging OCT probe (chapter 2) and MRI/OCT imaging 
system (chapter 3) are promising tools that can potentially transform the neurosurgery 
guidance, but we also need a simpler device that can be integrated with conventional 
guidance tools and improve their safety. 
Detecting blood vessels in front of a surgical probe in real-time is an important 
capability during interventional procedures. This may provide the ability to minimize 
laceration of vessels during stereotactic neurosurgery, avoid vessels during local 
anesthesia procedures deep inside the body, and locate vessels during central 
venous/arterial cannulation. Ultrasound is currently used for real-time image guidance 
and blood vessel localization for some of these interventional procedures. However, 
in some cases, such as neuraxial blockade, ultrasound guidance is especially 
challenging because of the complex encasement of bones that allows only a very 
narrow acoustic window for the ultrasound beam [171]. Furthermore, the guidance 
efficacy in some cases is still unsatisfactory due to limited resolution (~ 1 mm) and 
the need for complex hand-eye coordination [172]. Optical sensors that can be 
integrated with surgical tools and detect blood vessels in front of instruments provide 
a solution to these challenges.  
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An effective optical sensor needs to be small, flexible and rugged for integration 
with minimally invasive instruments. It also needs to have high lateral resolution (< 
100 m) to detect clinically significant blood vessels. Ideally, it should also have 
sufficient axial detection range to detect blood vessels millimeters ahead. Various 
optical technologies have been developed to monitor the blood flow. Laser Doppler 
flowmetry (LDF) has been used in neurosurgery [123], dermatology [173] and 
dentistry [174] to collect blood flow information. However, the resolution (mm-cm) 
of the two fiber design in a conventional LDF system is too coarse to allow location 
and avoidance of many vessels in the brain. Petoukhova et al. improved the axial 
resolution of LDF to 50 m by using coherence-gating effect [175]. Although this 
approach successfully obtained depth-resolved information from the human skin 
[176], the lateral resolution is not sufficient (few mm [175]) for neurosurgery. Also 
the two fiber design with wide separation in LDF system is not compatible with 
minimally invasive procedures. In contrast, Doppler optical coherence tomography 
(DOCT) creates a very small imaging spot (10 m) with a single fiber [135]. By 
scanning this spot, the flow information in the region of interest (ROI) can be mapped 
out with great resolution. However, in many clinical applications, it is not necessary 
to obtain high resolution images of blood vessels and accept the tradeoffs associated 
with imaging. Often what is needed is simply to determine whether there is a blood 
flow at a precise location in front of a surgical probe. We developed a technology to 
serve in such situations.  
Coherence-gated Doppler (CGD) is a real-time movement sensing technology that 




The system design is derived from time-domain DOCT or optical Doppler 
tomography (ODT) [135] with several important simplifications and modifications. 
By converting the DOCT imaging system to the CGD sensing system, the reference 
phase modulator, reference path length scanning, signal digitization and 
demodulation processing can be omitted. CGD only requires a simple electronic 
circuit to convert the Doppler beating signal to an audio signal. From the pitch and 
volume of the audio signal, we demonstrate that the simple CGD system enables us to 
differentiate tissue, vein and artery in live animals and also demonstrate that the CGD 
probe can potentially predict the creation of hematomas in neurosurgery.  
5.2 Material and methods 
5.2.1 System setup 
Fig. 5-1A illustrates the design of the CGD system. The light source is a 
superluminescent diode (SLD) at 1310 nm (Qphotonics QFLD-1300-10S).The 
wavelength bandwidth of the light source is 3 nm, and thus the coherence length is 
190 µm in water. The fiber (FC) coupler splits the photons to sample (90%) and 
reference arms (10%). The optical fiber circulator sends the illumination light from 
port 1 to port 2 and the backscattering light from port 2 to port 3. Both back scattering 
light from the sample and the reference mirror go to another fiber coupler (50/50) and 
the photons from each arm are re-distributed to two output fibers. The interference 
fringe from output fibers go to a dual balanced detection system, which rejects the 
common mode noise. After further amplification and frequency filtering (10 -20,000 




We also collect the signal by a data acquisition (DAQ) card (National Instrument NI-
6259) and process it with a computer (optional). The sampling rate of data acquisition 
is 400 kHz. The fiber probe consists of a single mode fiber (SM) and a GRIN 
multimode fiber (GM) for focusing (St. Jude Medical). The focal distance is 1.5 mm 
and the lateral resolution is 40 m. Fig. 5-1B and Fig. 5-1C illustrates DOCT and 
LDF system respectively. Please see the comparison between systems in chapter 2.5. 
 
Fig. 5-1. System comparison between CGD/DOCT/LD 
 (A) CGD system (B) Doppler OCT system (C) LDF system. SLD: superluminescent diode, LS: light 
source, BW: wavelength band-width, FC: fiber coupler, C: collimator, M: mirror, PM Phase 
modulator, ADC: analog to digital converter, SM: single-mode fiber, GM, gradient-index fiber, EM: 
emission fiber, RE, receiver fiber. The detection volume of each system is shown in the probe drawing 




5.2.2 Data processing 
The interference between two electric fields with Doppler frequency difference 
will generate a fluctuating AC signal, whose frequency is equivalent to the Doppler 
frequency difference. Therefore, the frequency of CGD waveform is equivalent to the 
Doppler frequency shift, which is linear proportional to the moving speed. The sign 
of signal does not reflect the flow direction. From the interference fringe, we can only 
measure the flow speed (the frequency) and the volume of moving scatters (the 
amplitude), but no information on the flow direction. To quantify the performance of 
the system, we record the interference fringe by a DAQ card (sampling rate 400 kHz) 
and calculate the M1 (first moment) factor, * ( )dP    which is linearly 
proportional to  the average concentration of the scatter multiplied by the root mean 
square of the velocity [177]. P(ω) is the power spectrum of the interference fringe. 
The power spectrum of the CGD waveform is calculated by taking Fourier transform 
and square the amplitude.  The time domain window for Fourier transform is 0.1 
second and the integration window on frequency domain is 0- 20 kHz. The M1 factor 
is used to characterize the linearity of speed measurement and detection volume. We 
also study the similarity of the time domain signal by autocorrelation. Firstly, we 
square the CGD waveform signal to avoid the cancelation between positive and 
negative signal. Then, we use the entire signal in the 5 seconds window to calculate 
the autocorrelation coefficient (Acorr) at different time shift (0-5 seconds). We also 
calculate the spectrogram from the CGD waveform. The theoretical minimum 
resolvable frequency is 0 Hz (DC) and the maximum resolvable Doppler frequency is 




PDB145C).  This frequency is corresponding to a flow speed of 9.75 m/s which is 
well above the fastest blood flow speed in human body (~ 1 m/s) [178]. In practice, 
the maximum frequency is determined by the sampling rate of data acquisition. In our 
study, the sampling rate is 400 kHz and thus the maximum frequency is 200 kHz 
(Nyquist limit). The minimum resolvable frequency is determined by the time 
window of short time Fourier transform (STFT), which is 0.1 second. Therefore, the 
resolution in frequency domain is 10Hz. The minimum (10 Hz) and maximum (200 
kHz) frequency are corresponding to Doppler velocity of 0.0065 mm/s and 130 mm/s 
respectively. The signal frequencies within human audible range (< 20 kHz) are 
displayed. A median filter is applied to improve visualization. 
5.2.3 Capillary phantom 
We constructed a vessel phantom by injecting 2% Intralipid solution through a 
capillary tube (I.D. = 0.4 mm), with the flow speed controlled by a motorized pump 
(Newport CMA-25CCCL). The velocity dynamic range, limited by the pump system, 
was 0.2-5 mm/s. 
5.2.4 In vivo rat femoral vessel detection  
All animal procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of Maryland, and animals were treated in 
accordance with the PHS Policy on Humane Care and Use of Laboratory Animals, 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals, 
and the Animal Welfare Act (7 U.S.C. et seq.). Anesthetized (ketamine 50 mg/kg and 




supine position have their femoral vessels exposed. The blood vessel color and 
relative position to the femoral nerve allow visual identification of the artery and vein. 
We place the CGD probe 3 mm away from the exposed vessels and translated the 
probe laterally to acquire information from tissue, vein and artery. The audio signal is 
recorded by a voice recorder (Sony, ICD-PX720). 
5.2.5 In vivo deep sheep brain vessel detection 
The effectiveness of the CGD probe was evaluated by examining its ability to 
detect vessels below the surface of the male sheep brain (wt. ~100 kg). Anesthesia is 
induced with 5 mg/kg ketamine (IV) and maintained under 1-4% isoflurane in 100% 
oxygen. After the sheep is deeply anesthetized, craniotomy is performed. The dura 
and pia membrane on the surface are carefully removed. Then, the CGD probe is 
inserted by hand. The inset of Fig. 5-2 shows the CGD probe placed in a 30 G needle 
and Fig. 5-2 shows the picture of a CGD probe being inserted into sheep brain in vivo.  
We also placed an US probe (Edge model, FUJIFILM SonoSite, Inc.), directly on top 
of the brain tissue to monitor the relative position between CGD probe and blood 






Fig. 5-2. A CGD probe during insertion into sheep brain.  
From ref. [137]. 
5.3 Results 
5.3.1 CGD system characterization 
Fig. 5-3 shows the linearity of the flow speed, as measured by the capillary 
phantom. CGD shows good linearity and the R-squared value is very close to 1. We 
also tested whether the CGD probe can resolve a capillary in a highly scattering 
environment. The vessel phantom was immersed in 2 % Intralipid solution, and the 
flow speed parallel to the probe is 1.5 mm/s. The inset of Fig. 5-4A shows the DOCT 
B-scan image of the capillary. We scanned the CGD probe across the vessel and Fig. 
5-4A shows the CGD probe can easily profile the parabolic flow in this 0.4 mm 
capillary (CGD probe is 0.4 mm away from the top surface of capillary). This result 
shows the great targeting capability of a CGD probe in a highly scattering 
environment. Also we characterized the axial detection range by placing the CGD 




CGD probe contacted the capillary and signal is close to the background signal level. 
From 0.18 - 0.71 mm the signal is significantly higher than the background level. 
 
Fig. 5-3. Linearity of flow speed measurement within two ranges.   
From ref. [137]. 
 
Fig. 5-4. Lateral and axial spatial specificity test of the CGD probe. 
(A) Signals measured while scanning the CGD probe (0.4 mm away from the top surface of capillary) 
laterally across a capillary tube immersed in 2% Intralipid solution. The inset shows a DOCT B-scan 
image of the phantom. The flow speed in the capillary is 1.5 mm/s parallel to the CGD probe. (B) 
Axial detection range. Moving a CGD probe axially away from a capillary immersed in 2% Intralipid 
solution. From ref. [137]. 
5.3.2 Rat femoral vessel flow measurements  
To test the feasibility of vessel detection and differentiation, we place the CGD 
probe on top of exposed rat femoral vessels (Fig. 5-5A). The femoral artery and vein 




movement). They are separated from each other by 1 mm. The CGD signals of the 
muscle tissue, vein and artery are also clearly apparent (Fig. 5-5B-D). Because the 
surrounding muscle tissue is not moving, its Doppler signal shows few high 
frequency components. After DC filtering, it has much smaller amplitude than the 
signal from the vessels.  Also, we can see that the bulk motion generated a sharp peak, 
which represents large volume of scatter moving all together. The signal from the 
vein (Fig. 5-5C) shows steady flow of blood cells, with frequency characteristics 
different from those of the pulsating artery (Fig. 5-5D). The pulsating voltage 
represents the variation of the volume of moving blood cells during a pulsation cycle. 
Note that the CGD probe can easily differentiate two vessels that are only 1 mm apart 
at the distance 3 mm away from the sample. This result demonstrates that the CGD 
probe can differentiate the neighboring vessels at a distal location far from the zero-
delay plane (the zero-delay plane is matched with the focal plane at 1.5 mm distance 
from the fiber surface). Unlike heterodyne detection which can only obtain the signal 
close to the zero-delay plane, homodyne detection enables us to obtain the signal 
along the illumination path. This capability provides us longer buffer distance before 
hitting the vessel, which can be beneficial for avoiding hemorrhage. The amplitude of 
artery is smaller than vein, because the thicker arterial wall allows less photons to 





Fig. 5-5. In vivo rat femoral blood vessel test. 
(A) Exposed rat femoral vessels and CGD probe inside a large outer guide. CGD probe is 3 mm away 
from the sample. Voltage waveform from (B) rat femoral tissue, (C) vein, and (D) artery. Arrow 
indicates bulk motion. From ref. [137]. 
 
 5.3.3 Sheep brain vessel detection 
Next, we tested the performance of the CGD needle probe (Fig. 5-2) for detecting 
vessels deep in the sheep brain. Fig. 5-6 shows the voltage waveform and the 
spectrogram from tissue (Fig. 5-6A), vein (Fig. 5-6B), and artery (Fig. 5-6C). When 
the CGD probe is surrounded by highly scattering brain tissues, any relative motion 
between the probe and the brain generates very strong Doppler signal. The 
spectrogram shows that the signal is strong (large volume of scatters) with focused 
frequency range (uniform speed). In contrast, the signal from a vein is more 
homogeneous in the frequency domain. The waveform of an artery shows the 
pulsation pattern, and the spectrogram reveals the speed variation during a pulsation 




during insertion) signal is mixed with the artery signal, it may be challenging to 
differentiate them in the spectrogram. However, if we study the similarity of the time 
domain signal by autocorrelation (Acorr), we can see the clear difference between the 
bulk motion and the artery. We find that the difference of the frequency distribution 
between different spikes in the bulk motion spectrogram generates irregular 
fluctuation on Acorr, which is distinctively different from the periodic Acorr of the 
artery. In Fig. 5-6A, from 4.5 second to 5 second (indicated by the red arrows), the 
probe is static and the motion is significantly lower than the signal in other time 
period. Acorr of the vein remains in a constant level due to the homogeneity of the 
signal.  
 
Fig. 5-6. CGD waveform, autocorrelation coefficient and spectrogram of brain vessels. 
 (A) Inserting the probe, (B) a vein, and (C) an artery in sheep brain in vivo. The red arrows indicate 





Fig. 5-7. Ultrasound imaging with the CGD flow detection in sheep brain in vivo  
Ultrasound monitoring with Doppler detection of the CGD probe as it approaches a vessel (yellow 
arrows) in a sheep brain in vivo. The CGD probe tip appears as the bright white spot (red arrows). 
The target vein is the blue spot in the insets in top panel. (A) Insertion motion away from the vein, (B) 
approaching the vein, and (C) pressing on the vein resulting in the disappearance of the ultrasound 
Doppler signal as well as the CGD signal. From ref. [137]. 
5.3.4 US-guided CGD vessel detection 
To verify that the CGD probe can detect blood vessels in highly scattering tissues, 
we pushed a CGD probe toward a blood vessel in the sheep brain under US guidance. 
Fig. 5-7A shows the situation when the probe (indicated by red arrow) is 1-4 mm 
away from the vessel (indicated by yellow arrow). The signal is dominated by 
insertion motion. The blood flow signal was initially detected at distance 3 mm in 
front of needle. Similar to the signal from the brain vessel data (Fig. 5-6A) the 
insertion motion has high intensity and focused frequency distribution.  As the probe 




distribution (Fig. 5-7B). Fig. 5-7B also shows the situation when the blood flow 
signal is mixed with insertion motion signal (indicated by black arrows).  Lastly, 
when the CGD probe comes in contact with the vessel, the blood flow signal initially 
becomes stronger followed by a loss of the CGD flow signal. The probe is advanced 
until it constricts the flow and the ultrasound signal is lost; the CGD signal also 
attenuates.  
5.4 Discussion 
We have developed a thin (0.125 m) and flexible CGD fiber probe that can 
detect at-risk blood vessels with real-time audio feedback up to 3 mm in front of 
advancing needle in brain tissue in vivo. The diffuse optics design of laser Doppler 
flowmetry (LDF) with sample volume in the mm to cm range often includes signal 
from surrounding tissues and thus is not ideal for applications required high spatial 
specificity. The CGD probe with confocal optics design enable us to target a 0.4 mm 
capillary (Fig. 5-4A) and differentiate blood vessels that are only 1 mm apart (Fig. 5-
5). On the other hand, Doppler optical coherence tomography (DOCT) has high 
spatial resolution (~ 10 m), high temporal resolution (40 Hz) and wide flow speed 
dynamic range (7 m/s to 52 cm/s) [160], but it requires extensive post processing 
and an expensive system to obtain the high resolution images. In contrast, CGD is a 
simple, robust and low-cost sensing system, which provides an audio signal that is 
rich in content, yet is easy for the operator to interpret (Fig. 5-5 & Fig. 5-6). Real-
time temporal resolution (10 Hz) and broad electronic detection bandwidth (10- 
20,000 Hz) allows us to differentiate the signals from artery, vein and motion artifact 




In order to achieve the best balance between the depth sensitivity and resolution, 
we carefully choose the 190 m coherence length (CL). In ideal case, we hope to 
detect a blood vessel few millimeters away with sub-mm lateral specificity. Shorter 
CL provides higher resolution but also limits the depth detection range.  We have 
used an SLD with 43 nm bandwidth at 1.325 m center wavelength and found that it 
can only detect a vessel within 60 m depth range, which is too short to prevent 
hemorrhage. Therefore, we further relax the detection range to 0.5 mm (Fig. 5-4B) by 
increasing the CL to 0.19 mm. In the animal study, Fig. 5-7 shows that it can detect a 
blood vessel that is 3 mm away due to longer transportation mean free path in the 
brain. On the other hand, if we further relax the CL to mm level, it may further 
improve the depth detection range, but may also include diffuse photons from the 
background tissue resulting in poor spatial specificity. We have to maintain the lateral 
resolution at sub-mm level in order to avoid the millimeter-sized blood vessels. 
Therefore, a light source with CL close to the mean free path of scattering tissues (~ 
0.1 mm [179]) provide us the best balance between the detection range and the 
resolution. 
We also choose the confocal probe design for optimal depth sensitivity. Without 
beam focusing and the confocal effect, a collimated beam may allow us to detect a 
blood vessel further ahead. However, in the scattering tissues, most of signal obtained 
by a parallel emitting probe will be from the tissue that is immediate proximal to the 
probe surface. On the other hand, a focused beam can deliver higher intensity to the 




probe. Therefore, a focused beam provides longer buffer distance before hitting the 
blood vessel than a collimated beam and thus has better chance to avoid hemorrhage. 
CGD is best suited for situations that require multitasking rather than tasks 
requiring precise image guidance. As shown in Fig. 5-5B, if the probe is static 
relative to the tissue, the amplitude of audio signal is low. When the probe reaches 
blood vessels, a high volume of flowing scatterers generates a much louder signal, 
and the artery shows a clear pulsatile pattern. From the spectrum analysis (Fig. 5-6), 
we find that the insertion motion has a narrow frequency distribution, while the 
movement of red blood cells in vessels is associated with a more homogeneous 
frequency distribution. The audio signals from blood vessels are more like white 
noise, which is clearly distinctive from the loud chirpy sounds associated with needle 
insertion (Fig. 5-6). The pulsatile nature of arterial flow clearly distinguish venous 
and arterial flow. Acorr analysis also shows the clear difference between insertion 
motion, vein and artery (Fig. 5-6). The downside of the Acorr analysis is that it 
requires a long time window (couple seconds) that includes several heart beats and 
thus it cannot be implemented in real-time system. However, in real surgery, most of 
instruments are advanced slowly and provide us long acquisition time. Also, since 
most of bulk motion signal are from the relative movement between the probe and the 
tissue, stopping the probe is actually the most effective way to suppress the motion 
signal (Fig. 5-6A 4.5 to 5 seconds). Therefore, we envision that the probe should be 
advanced slowly if a suspicious vessel is detected and then we can use the Acorr to 
analyze whether it is a pulsating artery. We will perform more animal experiments in 




One limitation of CGD is that it can only provide a semi-quantitative distance 
measurement based on the volume of audio signal. The strength of volume, however, 
also varies with the tissue scattering coefficient and the number of moving scatters. 
Therefore, we may detect blood vessels further away in the gray matter (low 
scattering) than in the white matter (highly scattering) and detect a large blood vessel 
further ahead than a small vessel. However, in the clinical settings, if there is a blood 
vessel with strong signal sitting ahead, we should stop the probe no matter how far it 
is from the vessel. In the future, we will perform more animal studies to determine the 
criteria for stopping the probe.  
It is worth to note that CGD may not detect small vessel (~ 10 m) at 90 deg 
angle when the probe is very close to the vessel. The mean free path (MFP) in brain 
tissue is around 0.15-0.3 mm [159]. Beyond this ballistic scattering regime, multiple 
scattering events effectively randomize the photon propagation direction resulting in 
random incident angles to the moving blood cells.  Therefore, we should be able to 
detect the laminar flow from any angle at the distance > 0.3 mm to the blood vessel. 
When the probe is proximate to the vessel, however, the illumination becomes more 
directional and the effective incident angle depends on the scattering property of 
blood cells. If the diameter of the vessel is comparable to the MFP of blood (~ 7 m 
[180]) , we will not be able to acquire the Doppler signal at 90 degree. For vessel that 
is much larger than 7 m, multiple scattering between blood cells will randomize the 
incident angle and enable us to acquire the Doppler signal from any angle. In the 




high-risk blood vessels that are millimeters in size. Under this circumstance, we 
should not encounter the angle issue. 
CGD probe is a great complimentary technology to tomographic techniques. We 
can use the wide filed-of-view tomographic imaging such as ultrasound to deliver the 
CGD probe to the region of interest and perform precise targeting with high precision 
(<0.1 mm) CGD local information/feedback. Fig. 5-7 shows that the CGD probe is 
capable of detecting blood vessels that are on average 3.4 ± 1.3 mm from the tip of 
the probe. With millimeters axial detection range and lateral tissue confinement, we 
can aim the probe to a brain vessel for tens of seconds (Fig. 5-7).The signal was 
found to become stronger when the CGD probe contacted the blood vessel. Further 
advances of the CGD probe resulted in the loss of both the CGD and the US Doppler 
signal and an ultrasound pattern suggestive of a hematoma is then formed in 
proximity to the blood vessel. On the other hand, many needle-based procedures are 
still performed without imaging guidance due to the limitations of technology. For 
example, in stereotactic neurosurgery, the skull blocks most of ultrasound signal and 
it is difficult to fit the ultrasound probe to the small opening along with surgical 
instruments. Therefore a thin CGD probe (<30 G) that can be easily integrated with 
surgical instruments and provide real-time feedbacks on local blood flow in front of 
the probe tip has great potential to improve the safety of these “blind” procedures. 
CGD probe is thin (~ 0.125 mm) and can be embedded within the outer tubing of the 
needle and can aim at the ROI by using forward or side viewing probes. Integrating 
fiber sensor with needle has been published previously [181]. A similar design can be 





Coherence-gated Doppler (CGD) provides the means for detecting blood flow 
with higher spatial resolution and with a smaller, more robust probe than 
conventional laser Doppler flowmetry at a cost of shorter depth of view. This tradeoff 
favors interventional procedures that require insertion of thin probes deep into tissue 

















Chapter 6:  Real-time Monitoring of Photo-immunotherapy 
Using Optical Coherence Tomography 
6.1 Introduction 
Photo-immunotherapy (PIT) is a  cell-specific cancer therapy with minimal 
side effects which is based on an armed antibody conjugate that induces rapid cellular 
necrosis after exposure to near-infrared (NIR) light. This novel treatment is developed 
by Dr. Hisataka’s group from NCI. The conjugate consists of a hydrophilic 
photosensitizer phthalocyanine dye, IR700, which is covalently bound to a humanized 
monoclonal antibody. When exposed to NIR light, the conjugate induces highly 
selective and rapid cancer cell death both in vitro and in vivo [16, 17]. It has been 
hypothesized that selective destruction of the perivascular layers of cancer cells by 
PIT leads to expansion of the tumor vessel diameter and results in a 24-fold increase 
in the accumulation of various nanomaterials in the tumor bed.  This effect is most 
marked for nano-sized molecules including nano-scale anti-cancer drugs and thus 
reflects a relative increase in permeability of vessels for larger molecules [18]. This 
effect has been termed super-enhanced permeability and retention (SUPR) to 
differentiate it from the more modest enhanced permeability and retention (EPR) that 
is commonly seen in tumors. Histology and fluorescence imaging with fluorescently 
labeled macromolecules, confirms that high concentrations of non-specific 
nanomaterials can permeate into the tumor bed after PIT. However, little is known 
about the specific effects of PIT on vessel size and blood flow changes at a 
microscopic level.  In this study, we used intra-vital optical coherence tomography 




6.2 Material and methods: 
6.2.1 Tumor model and PIT  
All in vivo procedures were conducted in compliance with the Guide for the Care 
and Use of Laboratory Animal Resources (1996), U.S. National Research Council, 
and approved by the local Animal Care and Use Committee. Six- to eight-week-old 
female homozygous athymic nude mice were purchased from Charles River (NCI-
Frederick). Two million A431 cells were injected subcutaneously in the right dorsum 
of the mice. Tumors reaching approximately 50 mm
3
 in volume were selected for 
study. The conjugate of panitumumab (antiEGFR antibody) and IR700 was 
synthesized as previously reported [17]. Briefly, panitumumab (1mg, 6.8nmol; 
Amgen, Thousand Oaks, CA, USA) was incubated with IR700 (IRDye 700DX NHS 
ester; 60.2μg, 30.8nmol, 5mmol/L in DMSO; LI-COR Bioscience, Lincoln, NE, USA) 
in 0.1 mol/L Na2HPO4 (pH 8.5) at room temperature for 30 min. The mixture (Pan-
IR700) was purified with a Sephadex G50 column (PD-10; GE Healthcare, 
Piscataway, NJ, USA). The protein concentration was determined with a Coomassie 
Plus protein assay kit (Thermo Fisher Scientific Inc., Rockford, IL, USA) by 
measuring the absorption at 595 nm with spectroscopy (8453 Value System; Agilent 
Technologies, Santa Clara, CA, USA). The concentration of IR700 was measured by 
absorption with spectroscopy and the number of IR700 molecules per panitumumab 
was adjusted to approximately 4. One hundred micrograms of Pan-IR700 was 
injected intravenously via the tail vein of a mouse 24 hours before PIT. The A431 
tumor was treated with continuous NIR irradiation by 690nm laser system (BWF5-






 for 10 min (100J/cm
2
). As controls, tumors in tumor bearing mice were 
irradiated by NIR without Pan-IR700 administration. 
6.2.2 OCT imaging system 
 
Fig. 6-1. Schematic of swept source OCT system.  
SS laser: swept source laser. FC: fiber coupler. PC: polarization controller. BD: balanced detector. C: 
collimator. O: objective lens. GSM: galvo scanning lens. M: mirror.    
One unique feature of OCT compared with conventional optical imaging 
modalities is its capability to resolve the information from different depths by using 
an interferometer. The interference fringe from different depths reveals the scattering 
intensity from the specific depth and has a characteristic oscillation frequency. By 
resolving signals with specific frequencies, a depth-resolved OCT image can be 
obtained. Fig. 6-1 shows the schematic of the swept-source OCT (SS-OCT) setup. 
The SS-OCT system[155-157] utilizes a wavelength-swept laser as its light source. 
Spectrum bandwidth of the laser is 100 nm centered at 1325 nm (Thorlabs, SL1325-
P16), which gives 10 µm axial resolution in tissue. The wavelength-swept frequency 




rate is equivalent to 16 frames per second (8 frames/s if only one direction is used). A 
Mach-Zehnder interferometer (MZI) receives 3% of the laser output power and uses it 
to generate a clock signal with uniformly spaced optical frequency to trigger the 
sampling of the OCT signal in the analog-to-digital (A/D) converter. The circulator 
sends the photons from port 1 to port 2 and reflected light from port 2 to port 3. The 
sample and reference arms of a Michelson interferometer receive equal portions of 
the remaining 97% of the laser power. The galvanometer scanning mirrors deflect the 
sample arm light into the sample through an objective lens, which provides 15 µm 
lateral resolution. The backscattering light from the tissue is recombined with the 
reflected light from the reference mirror, and the interference fringe is detected by the 
dual-balanced detector. The signal will be acquired by the data acquisition card (DAQ) 
and then be sent to the computer for image construction and display. 
6.2.3 Phantom studies 
Fig. 6-2A-B shows the results of the phantom study. Two imaging protocols, 
DOCT [182] and SV [134] are tested with a vessel phantom. The vessel phantom is a 
capillary tube with 0.4 mm inner diameter. Intralipid solution (1% volume 
concentration) was pushed through the tube at various speeds controlled by an 
injection pump (Fisher Scientific, Single Syringe Pump). Fig. 6-2A shows that SV 
can accurately map the lumen of vessel, but DOCT reaches a detection limit at low 
velocities. SV is capable of mapping out the vessel lumen, even when the bulk flow 
speed is zero. On the other hand, Fig. 6-2B shows that DOCT changes linearly with 




DOCT to measure the flow velocity and SV to measure vessel diameter. The standard 
deviation is calculated from 10 different images under a specific flow velocity. 
 
Fig. 6-2. Phantom studies and image algorithms 
 (A) Cross-sectional DOCT and SV images of a vessel phantom (0.4 mm inner diameter) at various 
flow velocity. (B) Total intensity of DOCT and SV versus flow velocity. (C) Real time motion 
detection using SV images (6 frames/s). Frame 259 and 266 shows the SV images when the tissue is at 
rest. Frame 263 and 264 shows the SV images when the tissue is moving. By locating the local 
minimum (indicated by the red triangles), we can isolate images with no motion. (D-G) Automatic 
ROI selection procedure. Fig. 6-2D is the original image with blood vessel and background noise. Fig. 
6-2E is binary conversion of Fig. 6-2D. Fig. 6-2F is an image with all the connected pixels labeled 
with a specific color. Noise is dramatically reduced when choosing the ROI with the largest area. Fig. 




6.2.4 Bulk motion and ROI  
During the in vivo experiment, tissue bulk motion can significantly degrade the 
image quality. For example, in Fig. 6-2C, when the tissue is moving (frame 263 & 
264), the SV contrast between the tissue and vessel is poor.  When the tissue is at rest 
(frame 259 & 266), the signal from the static tissue is reduced and the vessel is 
detectable. In Fig. 6-2C, we plot the total SV signal against the frame index. Since SV 
is decoupled with the blood velocity and only relates to the motion of scatters, the 
local maximum is not related to the pulsation but only reflects that the tissue is 
moving. Therefore, by searching the local minimum (marked by red triangles), we 
can easily distinguish  images with good vessel/tissue contrast from those disturbed 
by bulk motion and eliminate those frames with motion degradation.   DOCT images 
from frames with bulk motion are also removed from analysis.   
In order to accurately measure the vessel lumen, we implemented an 
algorithm which isolates the vessel signal from the background noise. Fig. 6-2D-G 
demonstrates the procedure using representative images. In the first step, we convert 
the image to a binary image (Fig. 6-2E). In the second step, we used a MATLAB 
built-in function to label the connected components (Fig. 6-2F). Fig. 6-2F shows that 
the connected pixels are then labeled in one color. The color with the largest area is 
selected as the region of interest (ROI). In the final step, we overlay this ROI with the 
original image to isolate the vessel signal from the background (Fig. 6-2G).  Since 
OCT cannot penetrate the entire diameter of large vessels, we cannot use the area of 




row is determined and the median measurement is chosen to represent the vessel size. 
Matlab code for ROI selection and bulk motion removal is attached in appendix B.  
6.2.5 Statistical analysis 
 Data are expressed as mean + standard deviation. Statistical analyses were 
carried out using MATLAB. Student t test was used to compare vessel size and flow 
speed of treated tumors to the untreated control. P < 0.05 was considered to indicate a 
statistically significant difference. 
6.2.6 Histopathologic evaluation 
Excised tumors underwent histopathologic examination after formalin fixation 
and paraffin embedding. All samples were then serially sectioned at 40 m intervals 
and stained with hematoxilin-eosin (H&E) or PECAM-1 (CD31, endothelial maker; 
company). 
6.3 Results                                                                                                                                                                                         
Fig. 6-3A-D shows the diameter and the blood velocity of a PIT-treated tumor 
blood vessel. OCT provides the structure information. DOCT provides the blood 
velocity information and SV provides the size of the open lumen. The first 60 
seconds, are obtained as a baseline before PIT. At 60 seconds, NIR 
irradiation(100J/cm^2) is turned on  and blood velocity quickly drops  below the 
detection limit. The open space in the vessel lumen also decreases with time, but 
remains open after 600 seconds of light irradiation. After 600 seconds, the NIR light 





Fig. 6-3. Vascular changes in a PIT-treated and control tumor blood vessel.  
(A-C) Representative OCT/DOCT/SV images at different time points (indicated by the orange dashed 
lines) during the PIT treatment. (D) Time plot of the blood velocity (red line) and the vessel width 
(blue line). In the first 60 seconds (indicated by the black dashed line), the laser light is off to obtain 
baseline information. After 60 seconds, NIR laser light is turned on for 10 minutes (60-660 seconds). 
The dosage is 100 J/cm^2. In the last 60 seconds (660-720 seconds), the light is turned off to obtain 
post-treatment information (indicated by the second black dashed line on the right). (E-G) 
Representative OCT/DOCT/SV images at different time points (indicated by the orange dashed lines) 
of a control tumor blood vessel (with NIR light, but no PIT drug) (H) Time plot of the blood velocity 
(red line) and the blood vessel width (blue line) of the control vessel. The dosage is 100 J/cm^2. (I) 
Ratio of vessel size and blood velocity in PIT-treated and control tumors (control is NIR irradiation but 
no PIT drug). The vessel size of PIT-treated vessels (n=4, from 3 mice) is slightly smaller than its size 
in the first minute, but it is not statistically significant (P>0.05) compared to the control (n=5, 3 mice). 
On the other hand, the blood velocity of PIT-treated blood vessels drops significantly in the end of 






The vessel size and the velocity remain at a relatively constant level after irradiation. 
At the beginning of irradiation, the DOCT image (Fig. 6-3A) demonstrates that blood 
velocity is high and the SV image shows a large lumen. 
After 83 seconds of irradiation, the DOCT image (Fig. 6-3B) shows that the 
velocity has significantly decreased, but the size of the lumen remains almost 
unchanged. The blood velocity drops below the detection limit after 372 seconds of 
irradiation, but the lumen remains open (Fig. 6-3C).  
Control experiments were performed on rats that did not receive the antibody-
photosensitizer conjugate but underwent light exposure. Fig. 6-3E-H shows that blood 
velocity and lumen size during the 600 seconds of NIR irradiation fluctuate 
moderately, which is probably due to physiologic variation and motion, but there is 
no  sustained blood velocity drop in the controls. Indeed, the images show that the 
blood velocity and the lumen size remains essentially the same throughout the 
measurement period.   
To quantify the effect of PIT,  the ratio of blood velocity and lumen size at the 
beginning and end of PIT (comparing the first and last minute during irradiation) was 
determined (Fig. 6-3I). PIT-treated group consisted of 4 tumor vessels from 3 
different animals. Control experiments (with irradiation but no drug) were performed 
on 5 tumor vessels from 3 different animals.  The lumen size of PIT-treated tumor 
vessels decreased with time (ratio is smaller than 1) but it is not statistically different 
from the control vessels (T test, P>0.05).  On the other hand, the drop in blood 
velocity in PIT-treated blood vessels was statistically different compared with the 




changes in vessel lumen diameter, there is a measurable acute decrease (more than 
one order of magnitude) in blood velocity in PIT-treated vessels.  
 
 
Fig. 6-4. Histology of the control and PIT treated tumor vessels. 
(A) Histology (H&E staining) of control peripheral tumor vessel. Intact blood vessels are indicated by 
the red arrows. (B) Histology (H&E staining) of PIT-treated peripheral tumor vessel. Intact blood 
vessels are indicated by the red arrows. (C) Histology (PECAM1 staining) of control central tumor 
vessel. The inset shows a zoom-in image. (D) Histology (PECAM1 staining) of PIT-treated central 
tumor vessel. The inset shows a zoom-in image. The scale bar represents 100 m.  
Fig. 6-4A-B demonstrates the histology of peripheral tumor blood vessels. 
With H&E staining, the red blood cells do not display a nucleus and can be found in 
the well-preserved blood vessels (indicated by the red arrows). The vessels in both 
control and PIT-treated tumor have well defined boundaries and are easily 




consistent with the in vivo result, which suggests blood vessels are not damaged. On 
the other hand, PECAM-1 staining (Fig. 6-4C-D), which labels the endothelial cells 
of blood vessels (brown color), demonstrates that the PIT-treated capillaries in the 
deep tumor bed are markedly dilated compared with the control vessels.  
6.4 Discussion 
There are several advantages of using OCT in this setting.  It allows us to 
monitor tumor vascular responses without the injection of a contrast agent or the 
implementation of an artificial tumor window chamber. Motion gating with speckle 
variance successfully overcomes the challenge of bulk motion artifact and permits in 
situ imaging without interfering with the tumor. This method requires fast imaging 
speed to obtain images not degraded by bulk motion from a breath cycle.  Since the 
normal mouse respiratory rate is around 3 breaths per second, according to the 
Nyquist sampling theory, imaging speeds >6 frames/s are necessary to record the 
entire cycle. High imaging frame rate limits the number of A-lines per image (more 
A-lines per image, slower frame rate) and thus limits the field of view. We used 1000 
A-lines per image within a 715 µm field of view (FOV) to achieve reasonable DOCT 
sensitivity.  FOV could be increased  by two orders to 71.5 mm while maintaining the 
same frame rate by using a laser source with two-orders faster wavelength sweep rate 
[183]. In addition, high-speed lasers can potentially enable 4D tissue images. Besides 
FOV, the spatial resolution could be further improved to observe the small vessel 
dilation. Micro-OCT [184] with a resolution of  1 µm in three dimensions will enable 




Unlike in most other ablative therapies, both in vivo SV imaging (Fig. 6-3A-
C) and histology images (Fig. 6-4B) verify that the peripheral tumor blood vessels 
remain intact during PIT treatment. Furthermore, speckle variance confirms that the 
vessels are filled with free moving blood cells and are not thrombosed.  An obstructed 
vessel would result in the absence of free moving scatters and the vessel would lose 
its variance contrast relative to static tissue, none of which was observed.   The 
vessels are open and filled with free moving blood cells. However, the central and 
peripheral vessels respond very differently. Due to the limitation of spatial resolution 
and penetration depth, only big (>100 m) peripheral tumor vessels are observed in 
vivo with OCT. These big peripheral vessels do not dilate (Fig. 6-3I), while the deep 
capillaries are markedly dilated (Fig. 6-4D). This heterogeneous response may be due 
to the difference in vessel structure. The thick peripheral vessels typically have full 
structures including muscular bundle in the wall, which make them less likely to 
change during PIT. 
Fig. 6-3A-D demonstrates that the blood velocity in peripheral tumor blood 
vessels drops significantly during PIT treatment, while the lumens of the vessels 
remain open. Blood velocity is maintained in control animals who received the 
conjugate but no light irradiation (Fig. 6-3D, 0-60 seconds) and the controls who 
received light irradiation but no conjugate (Fig. 6-3H). This blood velocity drop may 
be due to the increase of blood pool volume as a consequence of dilated central 
vessels. A much larger central blood pool volume as well as possible decreased 




In conclusion, PIT treatment acutely reduces blood speed while the blood 
vessel are undamaged or thrombosed. Slow blood flow speed implies long drug 
circulation time. On the other hand, dilated central vessels may lead to slow periphery 
flow and increase in drug pool volume in tumor vessels.  
In our next project, we will use multiphoton microscopy to observe the 
diffusion of the antibody-IR700 conjugate and estimate cancer cell viability in situ. 
This study will help elucidate how PIT destroys the perivascular barrier and enhances 



















Chapter 7: Conclusion and future direction  
7.1 Optical coherence tomography for neurosurgery 
Intra-operative neurosurgery guidance has seen significant advancements since 
the introduction of micro electrode recording (MER) and intra-operative MRI (iMRI). 
Despite the great guidance capabilities of these technologies, the fundamental 
limitations of MER and iMRI leave lots of room for improvement. MER is an 
accurate tool for locating brain nuclei by observing the distinctive neuron firing 
patterns, but it also increases the risk of disastrous intracranial hemorrhage, requires 
long operation hours, and is not capable of targeting white matter tracks. iMRI, in 
contrast,  is capable of locating different tissues (lesions, nuclei and white matter 
tracks) and avoiding hemorrhage. However, iMRI imaging suffers from low spatial 
resolution (1 mm), slow imaging speed (tens of minutes) and high cost. Therefore, 
iMRI is mostly used as a pre-/post-operative imaging tool and intra-operative 
guidance tools such as MER are still necessary during the surgery. 
Optical coherence tomography is a promising real-time guidance tool, because it 
is capable of imaging brain nuclei [40], lesion [185], fiber tracks [42] and brain blood 
vessels [41] simultaneously in real time. Dr. Tang’s group is the first to demonstrate 
that OCT can detect important tissue landmarks for neurosurgery guidance [40]. 
Moreover, they also demonstrated that a side-viewing OCT probe can guide the 




7.1.1 OCT needle probe 
By collaborating with Dr. Tang’s group, we developed the next generation of 
OCT probes for neurosurgery guidance[41] (chapter 3). Two fundamental 
improvements make this probe another step closer to clinical use: forwarding imaging 
and Doppler flow tomography. Forwarding imaging capability that enables the 
detection of blood vessels in front of the advancing probe is crucial for avoiding 
hemorrhage. There are various forward-imaging OCT probes which have been 
developed before this work, but they are too bulky to be integrated into neurosurgical 
tools. We overcame this challenge by relocating the actuator for laser scanning from 
the distal to proximal end and relaying the laser spot into the tissue through a static 
GRIN rod lens. This approach not only solves the size issue but also significantly 
improves the phase stability which results in high quality Doppler tomography. To 
the best of our knowledge, this is the first forward-imaging probe that can perform 
OCT and Doppler OCT simultaneously. Please see technique details in chapter 3. 
Currently, the major roadblock of the clinical translation of this device  is that the 
sensitivity is not comparable to MER. OCT contrast between the small nuclei targets 
and their surrounding tissues is not high enough. Polarization-sensitive OCT (PSOCT) 
can potentially solve this problem by providing additional birefringence contrast. In 
literature, six fold improvement of contrast has been reported[42]. Moreover, PSOCT 
enables us to measure the orientation of fiber tracks, which in combination with full 
brain micro-tractography[186] will further improve the accuracy of targeting . The 




orientation. Therefore if we can color code the fiber tracks in our full-track 
measurement , we will be able to better localize the probe. 
System wise, the device needs to be further minimized (Fig. 7-1) for the 
integration with a stereotactic frame. A needle guidance that could be hand-held by 
the surgeon is important for some applications. In the future, we can use 
microelectromechanical (MEMS) mirrors (Mirrorcle) to replace the bulky scanning 
mirrors, a high precision ferrule (Vitrocom) to replace the alignment stage and a small 
GRIN lens to replace the objective lens. Previously, we relied on an alignment stage 
to achieve oblique illumination to reduce the strong reflection from the proximal end 
surface of the GRIN needle, which significantly degrades the imaging quality. In the 
new design, we can process the end surface with an anti-reflection coating and angle-
cutting to solve this issue[151]. The GRIN rod lens that relays the scanning laser spot 
and collimates the laser beam is generally considered as polarization isotropic 
component and the PM fiber design allows us to actuate the sample arm without 
affecting the power distribution between two polarization channels. With these design 





Fig. 7-1. Miniaturization of OCT needle probe 
(A) Current OCT needle probe. (B) Schematic of miniaturized PSOCT probe. The collimator, C, will 
collimate the laser beam. After passing through quarter waveplate, Q, and being reflected by the mirror, 
M,  the laser beam will be projected on MEMS mirror, which will deflect the laser beam to the 
proximal end of GRIN rod lens, G, and scan the laser beam to perform 2D or 3D imaging. A high 
precision ferrule will align the focused spot from G to the GRIN needle, GN. Then, GN will relay the 
scanning laser spot into tissue. 
Besides neurosurgery, the OCT needle probe can be applied to other needle-based 
procedures requiring high-resolution visual feedback. For example, regional 
anesthesia, including neuroaxial and peripheral blocks, are traditionally performed 
using blind, landmark based approach. Together, they account for 6 million 
procedures annually in the US.  Due to lack of visual feedback to guide needle 
navigation, failure rate of epidural anesthesia is up to 20% [171], and the 
complication rate of peripheral nerve block approaches 10%, with the real potential 
for permanent nerve damage [187]. Ultrasound and ionizing fluoroscopy are the  two 




neuroaxial blocks, ultrasound guidance is especially challenging because of the 
complex, articulated encasement of bones that allows only a very narrow acoustic 
window for the ultrasound beam [171]. Fluoroscopy, on the other hand, has no soft 
tissue contrast, and therefore cannot identify blood vessels and nerves which are 
important to locate/avoid while inserting the anesthesia needle.   
 
Fig. 7-2. OCT needle probe for regional anethesia 
(A) Picture of a spine tissue cut along the sagittal plane. (B) Tip-front OCT images of fat, supraspinous 
ligament, interspinous ligament and flavum. 
Fig. 7-2 demonstrates the potential of using OCT needle probe for epidural 
anesthesia.  Fat tissue is featured with pockets of adipocytes. Ligaments are featured 
with bright and dark stripes due to birefringence effects. The supraspinous and 




thickness of fiber bundles. Flavum has bright (hyper-reflective) and homogenous 
scattering intensity. These soft tissue images can assist anesthesiologist to locate the 
position of needle.   
7.1.2 MRI/OCT 
Although OCT imaging devices provide useful visual feedback, its field of view 
(FOV) is limited (1-2 mm) due to tissue scattering. Therefore, many efforts have been 
made to combine OCT with volumetric imaging modalities, such as ultrasound [188]. 
However, combing OCT with MRI, one of the most powerful tool for neurosurgery, 
had not been done before this work [168] (chapter 4). There are two main technical 
challenges: (1) To create an MRI-compatible OCT imaging system without electrical 
motors or wires close to the region of interest and (2) To move or insert the probe 
inside the constrictive MRI bore.  
We solve these issues by incorporating a piezoelectric based OCT imaging system 
with an MRI compatible robot ( from Dr. Jay Desai’s group [166]).  The ex vivo 
human brain imaging demonstrates that OCT is a great complimentary technology to 
iMRI guidance. MRI/OCT multi-scale imaging achieves unprecedented 20 m 
resolution, which improves the accuracy of conventional MRI imaging (~ 1mm) by 
two orders. More importantly, OCT provides real-time (15 frames/s) structural 
information between the gap of high-resolution MRI images (exposure time is over 
15 minutes). In addition to the accuracy improvement, OCT provides a different 





The barriers for in vivo imaging includes: 1) lack of degrees of freedom and 2) 
OCT imaging distortion. The first issue can be solved by integrating the OCT system 
with an MRI robot with multiple degrees of freedom (a novel robot system developed 
by Dr. Jaydev Desai’s group) [189]. The second issue occurs because the flexible 
fiber is actuated at a distal site. Non-uniform scanning can be corrected by speckle 
correlation [170], which measures the distance between adjacent A-lines by studying 
the correlation of intrinsic speckle patterns.  Moreover, it is possible to incorporate 
Doppler OCT imaging with an advanced correction algorithm [190]. 
With the improved degrees of freedom and imaging quality, we can perform an in 
vivo study to test the system performance under the influence of physiological motion 
(breathing, etc.) and biofouling (bleeding, etc.). 
7.1.3 Coherence gated Doppler 
In some medical conditions, it is not necessary to obtain visual feedback and 
accept the tradeoffs associated with imaging, such as bulky device size (~ 1mm) or 
mechanical vibration noise from the actuator. For microelectrode recording (MER), 
for example, what is needed is a miniature sensor that can be easily integrated with 
the MER electrode and detect the at-risk blood vessels in front. Previously, laser 
Doppler (LD) probe has been used to monitor blood perfusion in human brain in vivo 
[123]. However, diffuse optics probe design of LD provides poor spatial specificity 
(mm-cm) and makes it difficult to be used for avoiding blood vessels.  
Coherence-gated Doppler (CGD) is a novel design, which is constructed by 
converting time domain OCT imaging system to a sensing system [137] (chapter 5). 




hemorrhage: 1) CGD has a much better lateral spatial resolution (< 100 m) than LD 
(mm-cm) and  2) CGD has much longer axial detection range (mm) than OCT (10 
m). These properties enable CGD to pick up the signal from the blood vessels few 
mm ahead without mixing it with the signal from surrounding vessels.  
The biggest challenge we currently face with CGD is motion artifacts. While the 
probe is inside highly scattering tissues, probe movements associated with surgical 
procedures will create a strong Doppler signal. This issue can be alleviated by moving 
the probe slowly. However, this is not practical in some cases. Another method to 
solve this issue is calculating cross-correlation between adjacent signal segments in 
time. The motion signal is fragmented and inhomogeneous in the frequency domain 
(chapter 5, Fig. 7-6) and thus has low cross correlation between signal segments. In 
contrast, the vessel signals are consistent and homogeneous in frequency domain and 
therefore adjacent signal segments are highly correlated. Therefore, calculating the 
signal cross-correlation between adjacent time segments should allow us to extract 
the vessel signal from the motion background. One tradeoff of this approach is that 
we need to reduce the temporal resolution to collect enough data for calculating the 
cross correlation. In the future, we should also perform more in vivo studies to 
determine the criteria of hazardous blood vessels, which should be avoided to reduce 
the risk of symptomatic hemorrhage. 
Besides avoiding vessels, CGD or LD can also be used to target vessels. Over 6 
million central venous and 8 million arterial catheters are placed each year [191].  
Due to lack of feedback, failure rates are often high, requiring multiple needle 




experience, up to 33% of needle-based interventions are associated with 
complications, of which some are fatal [192]. The likelihood of complication is also 
related to the number of failed attempts.  Compared to successful ocannulation after 
the first attempt, the incidence of mechanical complications after 3 attempts or more 
are six fold higher [192]. Such mechanical complications include bleeding, hematoma, 
pneumothorax, and vascular injury.  
Fig. 7-3 demonstrates the potential of using OCT/LD probe for targeting blood 
vessels. LD can detect blood flow beyond the OCT field of view (up to 5 mm) and 
provide audio feedback. When the probe is close to the blood vessel (within 1mm 
range),  OCT is capable of providing Doppler imaging to confirm whether the probe 
has contacted or punctured the vessel.  The first column of Fig. 7-3B depicts a 
cartoon and OCT/LD feedback when the blood vessel is out of range of the OCT 
imaging. The OCT image has relatively long penetration depth associated with 
muscle tissue and the DOCT detects no flow. However, the LD is more sensitive and 
can detect clear pulses. By following the audio feedback from LD system, we will 
approach the blood vessel. The second column depicts OCT/LD feedback when the 
probe is contacting the vessel. OCT is capable of differentiating the vessel wall 
(indicated by the red arrow) and DOCT can detect a flow signal beyond the vessel 
wall. Shallow penetration depth is observed for the OCT images when the probe is 
contacting the blood vessel. The last column depicts OCT/LD feedback when the 
probe has punctured the blood vessel and the vessel wall is no longer visible with 




When an interventional radiologist, cardiologist, neurosurgeon, etc advances a 
catheter in the vascular system he doesn’t really know if the tip is in the middle of the 
lumen of the vessel or pushing against the side of vessel that has a kink in it. He is 
forced to inject contrast dye and expose the patient and him to extra x-rays. There is 
increasing attention to how much radiation the patient and the physician are allowed 
to receive. Furthermore, the amount of contrast agent given to the patient is 
proportional to the risk of inducing renal failure, a serious concern and frequent 
complication. 
 
Fig. 7-3. OCT/LD probe for targeting blood vessels 
(A) A cartoon depicting the relative penetration depth of OCT and LD. LD can detect blood flow 
beyond the OCT field of view (up to 5 mm) and provide audio feedback. (B) A table demonstrating the 
feedback observed from the OCT/LD probe during surgical navigation towards a blood vessel.  
CGD can minimize this problem if it can provide continuous feedback on whether 




will sound different. Our ears are very good at telling subtle changes in sound. It is 
also much easier to multitask with visual and audio information simultaneously. The 
audio signal will not distract the radiologist who is looking at the monitor. 
 Another potential application of CGD will be pulp vitality measurements.  The 
current standard of care in pulpal diagnosis is based on sensibility of pulpal nerves to 
thermal and electrical stimuli. Studies have shown that these techniques are 
frequently inaccurate in diagnosing the pulpal vitality, because they rely on neural 
rather than vascular information. While studies are available that show relatively high 
sensitivity and specificity for these techniques [193, 194], these studies share a 
significant limitation in that the gold standard was determined after treatment, and 
thus many cases that likely needed treatment but were never treated were not included. 
In addition, the utility of traditional thermal and electrical pulp testing methods in 
traumatic cases is very much diminished, because it is well known that following 
trauma, pulpal nerves do not respond to testing for a few weeks or months, but regain 
responsiveness with time. To address these limitations, techniques using laser 
Doppler flowmetry [195, 196], infrared [197] and pulse oximetry [198, 199] have 
been introduced to accurately determine pulpal vitality. The major limitations of these 
methods have been the inability to limit detection of blood flow to the tooth (and not 
the gingival or periodontal tissues), the need to immobilize the patient’s head in 
relation to the probe by creating a customized stabilizing jig for each patient, the 
interference caused by enamel cracks or dental restorations and the reduction in size 
of the pulp space with age or following a traumatic injury. Therefore, these 




market today that would truly measure pulpal vitality. CGD has much confined 
sample volume that could reduce the noise from the surrounding gum tissues and 
should significantly improve the specificity. 
CGD can also be applied to non-vascular interventions: Detect changes in tissue 
at the probe tip as one pushes it forward (i.e. needle) into tissue. Examples include: 
Percutaneous catheterization of the biliary tree. Here the GI doctor inserts a 
needle blindly between the ribs and aims for the base of the liver where the bile ducts 
emerge. The goal is to place a thin cannula into the bile duct that is blocked for some 
reason (i.e. stone, cancer, or stricture). This is a particularly important procedure for 
Chinese in China, since liver disease is one of the most common if that the biggest 
killers in China. My former student who is now a resident in interventional radiology 
at UCSF is considering using OCT as guidance for this procedure. But I think it 
would be so much easier to listen for changes in the sound when the tip is in solid 
tissue vs inside the lumen of the bile duct with bile. We can also add a spectroscopy 
feedback fiber to detect the difference between blood (liver) and bile (duct). 
Spinal tap and epidurals. Here the CGD can be used in two ways. Currently, 
epidurals are carried out by the “loss of resistance” method where the anesthesiologist 
applies a gentle pressure on a syringe attached to the advancing needle. When the tip 
of the needle enters the epidural space the syringe pressure drops. The loss of 
resistance methods requires two hands and that the patient is motionless. We can 
build a unit consisting of a disposable pressurized syringe with an optical fiber 
embedded in the stylet that can detect flow at the tip of the needle. This would be far 




operate.For the spinal tap there will be no need to use the pressurized system. The 
fiber sensor will simply detect changes in movement within solid tissue to movement 
within fluid (CSF). OCT is too much technology for a relatively simple procedure. 
Coherence gated Doppler is orders of magnitude simpler and cheaper and therefore 
more feasible.  
7.2 Optical coherence tomography for cancer research 
  Optical coherence tomography, which can provide tissue microstructure, 
Doppler flow imaging and speckle variance angiography simultaneously in real time 
without any contrast agent is a powerful tool for preclinical animal study. In chapter 6, 
an OCT imaging platform with novel imaging algorithms for monitoring tumor 
microenvironment during PIT treatment is presented. By using speckle variance to 
remove the motion artifact, we can perform intra-vital OCT imaging on in vivo 
animals without an artificial window chamber, which may significantly affect the 
physiology of tumors.  Observations of the hemodynamic changes provides with a 
better understanding of the therapeutic mechanism of this new anti-cancer therapy.  
In the future, we plan to integrate fluorescence molecular imaging (FMI) with the 
needle device to study the variation of the permeability of tumor blood vessels during 
photo-immunotherapy (PIT). We will inject a fluorescence contrast agent through the 
tail vein and quantify how much fluoresce molecular is leaked into tumor bed. Fig. 7-
4 shows the schematic of the multi-model imaging needle system. The left side of Fig. 
7-4 is a SS-OCT system. In the sample arm, the GRIN lens will relay the laser spot 
into the tissue and collect the back scattered light. The fluorescence molecular 




mirror. The fluorescence excitation and emission light (yellow line, wavelength < 800 
nm) will be reflected by the dichroic mirror, while the long wavelength OCT light 
(red line, 1300 nm) will penetrate through the mirror. Two imaging modalities will be 
carefully co-registered. The emission fluorescence signal will be reflected by another 
dichroic mirror. Then, it will pass through an emission filter and finally reach the 
photomultiplier tube (PMT). The wavelength of the excitation laser, emission filter 
and dichroic mirror are chosen based on the excitation and emission properties of the 
selected fluorophores. This system can be readily adapted to image fluorophores with 
different excitation/emission wavelengths in the range of 400 – 800 nm. 
 
Fig. 7-4. Schematic of OCT/FMI imaging needle. 
FC: fiber coupler; PC: polarization controller; C: collimator, BD: balanced detector, MZI: Mach-
Zehnder interferometer (frequency clocks), DAQ: data acquisition board, M: mirror, GSM: galvo 
scanning mirror, O: objective lens, AS: alignment stages, GL: GRIN lens needle, D: dichroic mirror, 






Here are the itemized personal contributions that advance the field of biomedical 
imaging and sensing: 
• Developed one of the thinnest (O.D. 0.74 mm) forward-imaging needle-type 
Doppler OCT probe and demonstrated that the needle can target or avoid specific 
tissues in large animals in vivo.  The novel design that replaces the distal actuation 
with proximal actuation and a relay GRIN lens significantly reduces the needle size 
(from > 2mm to 0.74 mm) and enables the applications requiring minimal tissue 
damaging, such as neurosurgery and spine surgery. Furthermore, real time (8 frames/s 
with Doppler OCT) imaging speed, micrometer resolution (~ 10 m) and great soft 
tissue contrast (blood vessels, gray matter, white matter, ligament and nerve bundle) 
makes this system a promising platform technology for needle-based procedures. 
• Designed and constructed the first MRI compatible OCT imaging system that 
improves the accuracy of MRI-guided procedure by two orders to ~ 20 micrometer 
and provides an optical contrast that enhances the detection of MRI-occult tissue 
landmarks. Furthermore, concurrent and multi-scale MRI/OCT imaging could be 
used to correlate the functional MRI (fMRI) signal with high resolution optical signal 
to study the neural origins of fMRI signal.  
• Developed a cost-effective optical sensing system, coherence gated Doppler 
(CGD) to replace Doppler OCT in certain medical settings (reduced the system cost 
from $30,000 to $3,000). CGD probe has wider speed detection range (from mm/s to 
m/s) than phase sensitive Doppler OCT (< 1 mm/s) and provides better spatial 




• Investigated the super enhanced permeability and retention (SUPR) effect 
induced by photoimmunotherapy. Developed advanced imaging algorithms for 
tracking and quantifying the rapid hemodynamic changes during the therapy in 
tumor-bearing mice in vivo. Successfully extracted important physiological 







































%%%%%%%%%%%%%%%%%%%  Chia-Pin Liang  %%%%%%%%%%%%%%%%%%% 
  
%%%%%%%%%%%%%%%%%%%%% 
%Frames to read 
if nargin < 2 
    frame_start =1;            %Start Frame for DOCT processing (must be <= to 
"frame_stop") 
    frame_stop ='all';           %End Frame for DOCT processing (integer value > 0 or 




%Parameters for applying window function to fringe data (fringe_apodization) 
Contrast = 1.0; 
Brightness = 0; 
Scan = 'F';         % which scan will be processed: 'F' for Forward, 'R' for backward, 
'B' for both 
apodiz_method =  'Gaussian';  % 'Cosine', 'Gaussian', 
'Super_Gaussian','Hann','Hamming','Blackman', 'Nuttall', 'Blackman_Harris'*,'none' 
  
%%%%%%%%%%%%%%%%%%%%% 
%Parameters for phase-resolved Doppler OCT 
BulkMotionRemoval = 'H';    % 'H'-- histogram method; 'C'--- complex vector method, 
'N'--- none 
  
%Phase-resolved method or called autocorrelaton method 
dThreshold_Intensity = 40;          % OCT intensity threshold for Doppler image 
dThreshold_Variance = 0.1;         % OCT variance threshold for suppression of noise 
start_ref = 120;                     % start data point in every A line for bulk 
motion removal   
end_ref = 350;                      % end data point in every A line for bulk motion 
removal  
ref_points = end_ref-start_ref;     % data points for complex vector method of bulk 
motion removal 
bin_size = 128;                     % bin size used in histogram removal method 
shift_depth = 1;                    % step size in depth for sliding average window                 
shift_width = 1;                    % step size in width for sliding average window  
OCT_ave_depth = 1;                  % window length in depth for OCT sliding average 
window 
OCT_ave_width = 1;                  % window length in width for OCT sliding average 
window 
DOCT_ave_depth = 5;                 % window length in depth for DOCT sliding average 
window   
DOCT_ave_width = 5;                 % window length in width for DOCT sliding average 
window 




%Get OCT (.FRG) file name if there is no input argument 
if nargin < 1 
    msg1 = msgbox('Select OCT FRG Data File','Select File'); 
    uiwait(msg1); 
    pause(0.1); 
     
    %Get file name and file path of the fringe data 
    [filename, pathname] = uigetfile( ... 
       {'*.FRG','OCT FRG File (*.FRG)';'*.*', 'All Files (*.*)'}, ... 




    if pathname == 0 
        return 
    end 
    Filename = fullfile(pathname,filename); 
end 
  
%Read OCT fringe data from selected (.FRG) file 
[OCT_Fringe_3D, image_depth, nFr, frame_start, frame_stop] = 
Load_Thorlabs_DOCT_FRG_3D(Filename,frame_start, frame_stop); 
[FFT_length, image_width, Num_frame] = size(OCT_Fringe_3D); 
  
%Analyze OCT fringe data 
count=1; 
for frm_n = 1:Num_frame    %DOCT frames are doubled so only process every other one 
    %Display current Doppler frame number 
    index = frame_start + frm_n -1; 
    disp('%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%') 
    disp(sprintf('Processing Frame: %d',index)) 
     
    %Determine which scan to process ['F' for forward,'R' for backward,or 'B' for both] 
    if strcmpi(Scan,'F') 
        k_Fringe = OCT_Fringe_3D(:, 1:2:image_width, frm_n); 
    elseif strcmpi(Scan,'R') 
        k_Fringe = OCT_Fringe_3D(:, 2:2:image_width, frm_n); 
    elseif strcmpi(Scan,'B') 
        k_Fringe = OCT_Fringe_3D(:, :, frm_n); 
    end 
     
    %---------------------------------------------------------- 
    %Apply apodization to k domain spectral fringes using specified window function 
    k_Fringe = Fringe_apodization(k_Fringe, apodiz_method); 
  
    %Compute complex OCT fringes from k domain spectral fringes 
    OCT_complex = Compute_Analytical(k_Fringe, FFT_length, image_depth); 
  
    %Calculate average OCT signal, doppler phase shift, variance, and phase images 
    [OCT_Intensity dPhase dVariance] = 
Phase_Resolve_DOCT(OCT_complex,BulkMotionRemoval,dThreshold_Intensity,... 
        
dThreshold_Variance,start_ref,end_ref,ref_points,bin_size,shift_depth,shift_width,OCT_
ave_depth,OCT_ave_width,... 
        DOCT_ave_depth,DOCT_ave_width); 
     
    %Convert OCT intensity image to dB scale and rescale to [0, 255] 
    OCT_Display = OCT_mapping(OCT_Intensity, Contrast, Brightness); 
  
    %---------------------------------------------------------- 
    %Zero pad the end to restore original image dimensions from the averaging window 
%     OCT_Display=[[OCT_Display zeros(size(OCT_Display,1),DOCT_ave_width+1)]; 
zeros(DOCT_ave_depth,size(OCT_Display,2)+DOCT_ave_width+1)];     
%     dPhase=[[dPhase zeros(size(dPhase,1),DOCT_ave_width+1)]; 
zeros(DOCT_ave_depth,size(dPhase,2)+DOCT_ave_width+1)];     
  
    %---------------------------------------------------------- 
    %Plot images 
%     figure; imagesc(OCT_Display); colormap(gray(256)); colorbar; axis image; 
%     figure; imagesc(dPhase); colormap(DOCT_Colormap(256)); colorbar; axis image; 
caxis([-pi pi]); 
                 
    %---------------------------------------------------------- 
    %Pre-allocate variables 
    if frm_n == 1 
        OCT_Display_Complete=zeros([size(OCT_Display) frame_stop-frame_start+1]) ;   
%OCT intensity image 
        dPhase_Complete=zeros([size(dPhase) frame_stop-frame_start+1]) ;             
%Doppler OCT phase image 
        dVariance_Complete=zeros([size(dVariance) frame_stop-frame_start+1]);        
%Doppler variance image 
    end 
     




    %Store XZ image results in 3D matrices 
    OCT_Display_Complete(:,:,count)=OCT_Display;    %OCT intensity image 
%     hFigure0=figure(0); 
%     imagesc(OCT_Display); 
%     colormap(gray(256)); 
%     colorbar('vert'); 
%     title(['Frame ', num2str(index)]) 
%     pause(0.1); 
     
    dPhase_Complete(:,:,count)=dPhase;        %OCT doppler image 
%     hFigure1=figure(1); 
%     clim = [-pi, pi]; 
%     imagesc(dPhase,clim); 
%     colormap(dmap); 
%     colorbar('vert'); 
%     title(['Frame ', num2str(index)]); 
%     pause(0.1); 
  
    dVariance_Complete(:,:,count)=dVariance;     
%     hFigure=figure(4); 
%     clim = [0.5, 1]; 
%     imagesc(dVariance, clim) 
%     colormap(hot) 
%     colorbar('vert') 
%     title(['Frame ', num2str(index)])    
%     pause(0.1); 
  




%Unwrap DOCT images 




%Convert Doppler phase-shift (rad) to vertical velocity component(Vz) 
lambda=0.001320;  %(mm) central wavelength of laser source (1320 nm) 
if strcmpi(Scan,'B') 
    f_a=16000;   %axial scanning frequency (Hz) 
else 
    f_a=8000;   %axial scanning frequency (Hz) 
end 
n=1.33;      %index of refraction for scattering medium (e.g. tissue) 
dVelocity_Complete = (lambda*f_a/(4*pi*n)).*dPhase_Complete;  %velocity = mm/sec 
  
%---------------------------------------------------------- 
%Correct image aspect ratio 
% [OCT_Display_Final dVelocity_Final DOCT_FlowRate 
XSect_Area]=DOCT_AspectRatio_AreaIntegration(OCT_Display_Final,dVelocity_Final); 
  
%OCT/DOCT image overlay 
% [FusedImage]=OCT_DOCT_Overlay(OCT_Display_Final,dVelocity_Final); 
  
%----------------------------------------------------------     
%Assign variable to workspace 
% if exist('OCT_Display_Complete','var'); 
assignin('base','OCT_Display_Complete',OCT_Display_Complete); end; 
% if exist('dPhase_Complete','var');      
assignin('base','dPhase_Complete',dPhase_Complete); end; 
% if exist('dVelocity_Complete','var');   
assignin('base','dVelocity_Complete',dVelocity_Complete); end; 
% if exist('dVariance_Complete','var');   
assignin('base','dVariance_Complete',dVariance_Complete); end; 
% if exist('DOCT_FlowRate','var');        
assignin('base','DOCT_FlowRate',DOCT_FlowRate); end; 
% if exist('XSect_Area','var');           assignin('base','XSect_Area',XSect_Area); 
end; 







%Save variables in MAT file 
% [path name]=fileparts(Filename); 
% save(fullfile(path,[name,'_VARS.mat']),'OCT_Display_Complete','OCT_Display_Final',... 






function [OCT_FRG_3D, depth, nFr, frame_start, frame_stop] = 
Load_Thorlabs_DOCT_FRG_3D(f_name,frame_start, frame_stop)  
%Load calibrated spectral fringes in k domain from "frame_start" to "frame_stop"       
  
%Read File Header 
fid = fopen(f_name, 'rb' );     %open link with FRG file ['rb' = read ('r') with full 
precision ('b')] 
% disp(f_name)          %display FRG filename 
file_id = fread( fid, 16, 'uchar');        % File identification string 
file_head = fread( fid, 6, 'int32' );      % File_header 
nFr = file_head(1);                        % Number of images saved in the file 
width = 992;                      % Image width 
% width = file_head(2);                      % Image width 
depth = file_head(3) ;                     % Image depth 
nFrp3D = file_head(4);                     % Number of frames in each 3D volume 
n3D = file_head(5);                        % Numer of 3D volumes 
FFT_length = file_head(6);                 % FFT_length for OCT fringe 
if FFT_length == 0 
    FFT_length = 2*depth; 
end 
junk = fread(fid,118,'int32');             % Reversed bytes 
  
frmLenBytes = 40 + width * FFT_length * 2;  % number of bytes per frame (40 bytes is 
the length of sub header) 
frmNpixels = FFT_length * width;    %number of pixels per frame 
  
if strcmpi(frame_stop,'all') 
    frame_stop=nFr; 
end 
  
%Read out frame fringe data 
if frame_start > nFr 
   disp(sprintf('frame_start larger than number of total frames: %d',nFr)) 
   frame_start = nFr; 
   disp(sprintf('frame_start re_assigned to %d',nFr)) 
end 
  
if frame_stop > nFr 
   disp(sprintf('frame_stop larger than number of total frames: %d',nFr)) 
   frame_stop = nFr; 
   disp(sprintf('frame_stop re_assigned to %d',nFr)) 
end 
  
fseek(fid, (frame_start-1)*frmLenBytes, 'cof'); 
total_frames=frame_stop-frame_start+1; 
frmId = 0; 
  
%Save frame fringe data to 3D variable 
OCT_FRG_3D=zeros(FFT_length,width,total_frames); 
for frame_n = frame_start:frame_stop 
    frmId = frmId + 1; 
    disp(sprintf('...Frame loaded: %d',frame_n)) 
    elapsed_time(frmId) = fread( fid, 1, 'int32' ); 
    frame_info = fread( fid, 36, 'int8' ); 
    frame_data = fread( fid, frmNpixels, 'int16' ); 
    frame_data = reshape(frame_data, FFT_length, width); 
    OCT_FRG_3D(:,:,frmId) = frame_data; 
end 
  









function Fringe_apodiz = Fringe_apodization(Fringe_k, apodiz_method) 
%%%%%%%%%%%%%%%%%%%%%%%%Inputs%%%%%%%%%%%%%%%%%%%%%%%% 
% Fringe_k = fringe data from OCT scan  
% apodiz_method = 'Cosine', 'Gaussian', 'Super_Gaussian','Hann','Hamming', 
            %'Blackman', 'Nuttall', 'Blackman_Harris'*,'none' 
  
%%%%%%%%%%%%%%%%%%%%%%%%Outputs%%%%%%%%%%%%%%%%%%%%%%%% 
% Fringe_apodiz = fringe data with applied window function 
  
%----------------------------------------- 
%Window function for OCT fringe data apodization 
[index_length, width] = size(Fringe_k); 
window_band = 0.5*index_length; 
depth_index = (1:index_length) - round(index_length/2); 
  
switch apodiz_method 
    case 'Kaiser' 
         disp('Kaiser window') 
         alpha = 2; 
         index = (1:index_length)-1; 
         v = pi*alpha*sqrt(1 - (2*index/(index_length-1) -1).^2); 
         window = (besseli(0,v)./besseli(0,pi*alpha))'*ones(1,width); %'Kaiser' 
    case 'Cosine' 
         disp('Cosine window')    
         window = cos(pi*depth_index./index_length)'*ones(1,width); %'Cosine' 
    case 'Super_Gaussian' 
         disp('Super Gaussian window') 
         window = exp(-(depth_index./window_band).^4)'*ones(1,width); %'super 
Gaussian' 
    case 'Gaussian' 
         disp('Gaussian window') 
         window = exp(-(depth_index./window_band).^2)'*ones(1,width); %'Gaussian' 
    case 'Hamming' 
          disp('Hamming window') 
         window =(0.53836 - 0.46164*cos(2*pi*(1:index_length)./(index_length-
1)))'*ones(1,width); %Hamming 
    case 'Hann' 
          disp('Hann window')     
          window = (0.5 - 0.5*cos(2*pi*(1:index_length)./(index_length-
1)))'*ones(1,width); %Hann 
    case 'Blackman' 
          disp('Blackman window')        
          window =(0.42 - 0.5*cos(2*pi*(1:index_length)./(index_length-1)) + ... 
             0.08*cos(4*pi*(1:index_length)./(index_length-1)))'*ones(1,width); 
%Blackman 
    case 'Nuttall' 
          disp('Nuttal window')      
          window =(0.355768 - 0.487396*cos(2*pi*(1:index_length)./(index_length-
1))+ ...    
              + 0.144232*cos(4*pi*(1:index_length)./(index_length-1))- ... 
              0.012604*cos(6*pi*(1:index_length)./(index_length-1)))'*ones(1,width); 
%Nuttall 
    case 'Blackman_Harris' 
          disp('Blackman_Harris window')      
          window =(0.35875 - 0.48829*cos(2*pi*(1:index_length)./(index_length-1))+ ...    
              + 0.14128*cos(4*pi*(1:index_length)./(index_length-1))- ... 
              0.01168*cos(6*pi*(1:index_length)./(index_length-1)))'*ones(1,width); 
%Blackman_Harris 
     otherwise 
         disp('Rectangular window') 
         window = 1;    %Rectangular 
end 









function OCT_complex = Compute_Analytical(Fringe, FFT_length, image_depth) 
  
%Calculte complex OCT fringes from the k domain spectral fringes 
complex_temp = ifft(Fringe,FFT_length); 
  
%Cut off the mirror conjugate image 
OCT_image = abs(complex_temp(1:image_depth,:)); 
  
%Take last 1/10 pixels of A-line for calculation of the noise level 
aver_fract = 1/10; 
aver_pixel = round(image_depth*aver_fract); 
level_noise = sum(OCT_image((image_depth - aver_pixel):image_depth,:))/(aver_pixel+1); 
level_noise_matrix = ones(image_depth,1)*level_noise; 
  
%Normzlize the OCT complex signal to the noise background 






function [OCT_Intensity dPhase dVariance] = Phase_Resolve_DOCT(complex_signal, 
BulkMotionRemoval,... 
    
dThreshold_Intensity,dThreshold_Variance,start_ref,end_ref,ref_points,bin_size,shift_d
epth,shift_width,... 
    OCT_ave_depth,OCT_ave_width,DOCT_ave_depth,DOCT_ave_width)   
  
%Display bulk removal method 
disp(['Bulk Motion Removal Method = ',BulkMotionRemoval]);  
  
OCT_area = OCT_ave_depth*OCT_ave_width;  % number of data points in OCT sliding 
average window 
DOCT_area = DOCT_ave_depth*DOCT_ave_width;  % number of data points in DOCT sliding 
average window 
  
%Get size of data for Doppler calculation  
[data_depth data_width] = size(complex_signal); 
  
% data_re and next_re are adjacent real part of the complex A-line signal 
% data_im and next_im are adjacent imag part of the complex A-line signal 
data_re = real(complex_signal(:,1:data_width-1)); 
data_im = imag(complex_signal(:,1:data_width-1)); 
next_re = real(complex_signal(:,2:data_width)); 
next_im = imag(complex_signal(:,2:data_width)); 
clear complex_signal 
  
if BulkMotionRemoval == 'C' 
    %Calculate intensity threshold used in complex vector bulk motion removal method 
    dThreshold_Intensity_ref = dThreshold_Intensity - 10*log10(DOCT_area); 
  
    %Complex vector method for bulk motion removal 
    [next_re, next_im] = bulk_removal(data_re, data_im, next_re, next_im,start_ref, 
end_ref, ref_points, dThreshold_Intensity_ref);  
end 
  
%Calcualte OCT intensity image 
dR1 = data_re.^2 + data_im.^2; 
  
%Calculate real and imaginary components of Doppler signal using adjacent complex A-
scan fringes  
dRx =  data_re.*next_re + data_im.*next_im; %real component 
dRy =  data_im.*next_re - data_re.*next_im;  %imaginary component 
clear  data_re data_im next_re next_im  
  
%Calculate the image size for intensity, dPhase, and dVariance images  
img_depth = floor((data_depth - DOCT_ave_depth)/shift_depth); 
img_width = floor((data_width - DOCT_ave_width - 1)/shift_width);   %-1 to account for 





%Pre-allocate variables  
OCT_Intensity = zeros(img_depth, img_width); 
dRR1 = zeros(img_depth, img_width); 
dRX = zeros(img_depth, img_width); 
dRY = zeros(img_depth, img_width); 
  
%Calculate OCT intensity, and real and imag components of Doppler signal by sliding 
average window 
%hWait = waitbar(0,'Computing Doppler OCT'); 
for j = 1:img_width 
  for i = 1:img_depth 
      %OCT Intensity Window Range 
      OCT_depth_win1 = (i-1)*shift_depth + 1; 
      OCT_depth_win2 = (i-1)*shift_depth + 1 + OCT_ave_depth; 
      OCT_depth_range = OCT_depth_win1:OCT_depth_win2;       
      OCT_width_win1 = (j-1)*shift_width + 1; 
      OCT_width_win2 = (j-1)*shift_width + 1 + OCT_ave_width; 
      OCT_width_range = OCT_width_win1:OCT_width_win2; 
       
      %Doppler OCT (DOCT) Window Range 
      DOCT_depth_win1 = (i-1)*shift_depth + 1; 
      DOCT_depth_win2 = (i-1)*shift_depth + DOCT_ave_depth; 
      DOCT_depth_range = DOCT_depth_win1:DOCT_depth_win2;       
      DOCT_width_win1 = (j-1)*shift_width + 1; 
      DOCT_width_win2 = (j-1)*shift_width + DOCT_ave_width; 
      DOCT_width_range = DOCT_width_win1:DOCT_width_win2; 
       
      %Calculations 
      OCT_Intensity(i,j) = sum(sum(dR1(OCT_depth_range,OCT_width_range))); %intensity 
(using OCT window) 
      dRR1(i,j) = sum(sum(dR1(DOCT_depth_range,DOCT_width_range)));  %intensity (using 
DOCT window) 
      dRX(i,j) = sum(sum(dRx(DOCT_depth_range,DOCT_width_range)));  %real component 
      dRY(i,j) = sum(sum(dRy(DOCT_depth_range,DOCT_width_range)));  %imaginary 
component                 
  end 




clear dR1 dRx dRy  
  
%Calculate freq-shift (or phase-shift) and variance of Doppler OCT signal 
dPhase = atan2(dRY./(DOCT_ave_depth*(DOCT_ave_width-
1)),dRX./(DOCT_ave_depth*(DOCT_ave_width-1))); 
dVariance = 1 - sqrt(dRX.^2 + dRY.^2)./dRR1; 
  
%---------------------------------------------------- 
if BulkMotionRemoval == 'H' 
    %Histogram method for bulk motion removal 
    dPhase = BulkMotionRemoval_Histogram(dPhase,start_ref,end_ref,bin_size);   
end 
  
%Suppress noise where singal intensity is small than the intensity threshold 
dPhase(10*log10(dRR1) < dThreshold_Intensity) = 0; 
dVariance(10*log10(dRR1) < dThreshold_Intensity) = 0; 
  
%Suppress velocity noise where variance is small than the variance threshold 
dPhase(dVariance < dThreshold_Variance) = 0; 
  
%Renormalize the OCT intensity by the number of pixels in the sliding average window 





function OCT_display = OCT_mapping(OCT_linear, Contrast, Brightness) 
  
[height width]= size(OCT_linear); 
  




[Aline_max Aline_pos] = max(max(OCT_linear));  % find max intensity in OCT image 
  
%Calculate of the noise backgroud at the refrence A-scan 




%Calculate dynamic range of OCT image 
dB_Range = 10*log10(Aline_max/noise_level); 
  
%Convert OCT signal in linear scale into dB and map it to range [0, 255]   
OCT_log = (10*log10(OCT_linear/Aline_max) + dB_Range)/dB_Range*255; 
  
%Remap OCT image using Contrast and  Brightness settings 
OCT_display = Contrast*(OCT_log) + Brightness; 
OCT_display(OCT_display > 255) = 255; 






function [next_re, next_im] = bulk_removal(data_re, data_im, next_re, next_im, 
start_ref, end_ref, ref_points, dThreshold_Intensity_ref) 
  
%Bulk motion removal in complex domain using a complex vector 
[data_depth, data_width] = size(data_re); 
  
for k = 1:data_width 
    %Reset variable values 
    tempX = 0; 
    tempY = 0; 
    tempR = 0; 
  
    %Start referece of every A-line 
    j = start_ref; 
    ref_num = 0; 
    %For evey A-line, find intensity data points that is large enought in the 
reference range  
        % and accumulate the real--X and imag-- Y part of the Doppler signal of the 
bulk motion  
    while (ref_num < ref_points) && (j>=start_ref) && (j<=end_ref) 
    tempR = next_re(j,k).*next_re(j,k) + next_im(j,k).*next_im(j,k);    
    if (10*log10(tempR) > dThreshold_Intensity_ref); 
       tempX = tempX + (data_re(j,k).*next_re(j,k) + data_im(j,k).*next_im(j,k)); 
       tempY = tempY + (data_im(j,k).*next_re(j,k) - data_re(j,k).*next_im(j,k)); 
       ref_num = ref_num +1; 
    end 
    j = j +1; 
    end 
    %Calculate the Doppler power  
    tempR = sqrt(tempX.^2+ tempY.^2); 
  
    %When the number of data points is large than half of the 
        % reference data points, calculate the normalized real and imag 
        % part of the Dopperl signal of the bulk motion 
    if (ref_points~=0) && (ref_num > ref_points/3) 
        tempX = tempX/tempR ; 
        tempY = -tempY/tempR;  
    else 
        tempX = 1; 
        tempY = 0; 
    end 
    %Remove bulk motion from every other A-line fringes 
    dR = next_re(:,k).*tempX + next_im(:,k).*tempY; 
    next_im(:,k) = next_im(:,k).*tempX -next_re(:,k).*tempY; 











function KasaiClean=BulkMotionRemoval_Histogram(Kasai, lascan, uascan, bin_size) 
%Histogram Algorithm 
%Define Bulk Motion Removal Paramaters 
%This function accepts the doppler image (you can use 1 line of the  
%doppler image at a time or all 512 lines depending on how your code works) 
%lascan defines the start of the tissue region (top of image is 1) 
%uascan defines bottom of the tissur region. 
%I would suggest setting it up so that lascan and uascan are fixed at first 




half_bin_size = bin_size/2; 
  
%Remove bulk motion for each A scan 
for i=1:size(Kasai,2) 
    clear HKasai 
    clear MaxKasai 
  
    %Determine the phase shift of the majority of pixels using a 
    %histogram of the a scan with specified bin size. 
    HKasai=hist(Kasai(lascan:uascan,i), -pi:(2*pi/(bin_size-1)):pi); 
    A=mean(find(HKasai==max(HKasai))); 
     
    %Rotate A scan data between [-pi pi] so that the peak of the histogram  
    %zero-centered (i.e. the maximum phase shift is shifted to zero). 
    if (A > half_bin_size)  
        MaxKasai=(A-half_bin_size)*pi/half_bin_size; 
    else 
        MaxKasai=-(half_bin_size-A)*pi/half_bin_size; 
    end 
    Kasai(:,i)=-Kasai(:,i)+(MaxKasai); 
  
    %Wrap the phase again after zero-centering the histogram peak  
    outside_lower=find(Kasai(:,i) < -pi); 
    Kasai(outside_lower,i)=Kasai(outside_lower,i)+(2*pi);     
    outside_upper=find(Kasai(:,i) > pi); 
    Kasai(outside_upper,i)=Kasai(outside_upper,i)-(2*pi); 
     
    clear outside_upper 

























Matlab code for ROI selection, bulk motion remove and DOCT unwarpping. 
 
% Combinging multiple mat files to one file with selected frame inteval 
% Should have OCT3D, DOCT3D and SV files ready before using this program 
  
finterval=5; % frame interval 
[filename,pathname] = uigetfile( ... 
       {'*.mat','mat Files (*.mat)';'*.*', 'All Files (*.*)'}, ... 
        'Select files','MultiSelect','on'); % select all OCT3D files for merging. 
    for i=1:length(filename) 
        Filename = fullfile(pathname,filename{i}); 
        [a,b]=fileparts(filename{i}); 
        SVfname=strrep(b,'_OCT3D','_SV.mat'); 
        DOCTfname=strrep(b,'_OCT3D','_DOCT3D.mat'); 
        PVfname=strrep(b,'_OCT3D','_Variance3D.mat'); 
         
        OCTFname=Filename; 
        SVFname=fullfile(pathname,SVfname); 
        DOCTFname=fullfile(pathname,DOCTfname); 
        PVFname=fullfile(pathname,PVfname); 
  
         
        oct=load(OCTFname); 
        OCT=oct.OCT_Display_Complete; 
        OCT=OCT(:,:,1:finterval:end); 
         
        doct=load(DOCTFname); 
        DOCT=doct.dVelocity_Complete; 
        DOCT=DOCT(:,:,1:finterval:end); 
         
        sv=load(SVFname); 
        SV=sv.SV;  
        SV=SV(:,:,1:finterval:end); 
         
        pv=load(PVFname); 
        PV=pv.dVariance_Complete;  
        PV=PV(:,:,1:finterval:end); 
         
                
        if i<=1; 
            OCT_C=OCT; 
            DOCT_C=DOCT; 
            SV_C=SV; 
            PV_C=PV; 
        else 
            OCT_C=cat(3,OCT_C,OCT);% Combing multiple files. 
            DOCT_C=cat(3,DOCT_C,DOCT); 
            SV_C=cat(3,SV_C,SV); 
            PV_C=cat(3,PV_C,PV); 
  
        end 
    end 
         
        Of_name='m2l_OCT_C.mat'; 
        Df_name='m2l_DOCT_C.mat'; 
        SVf_name='m2l_SV_C.mat'; 
        PVf_name='m2l_PV_C.mat'; 
        Ooutpath=fullfile(pathname,Of_name); 
        Doutpath=fullfile(pathname,Df_name); 
        SVoutpath=fullfile(pathname,SVf_name); 
        PVoutpath=fullfile(pathname,PVf_name); 
  
        save(Ooutpath,'OCT_C'); 
        save(Doutpath,'DOCT_C'); 
        save(SVoutpath,'SV_C');  
















plot(locs,b(locs)+0.05,'k^','markerfacecolor',[1 0 0]); 












% measuring the lateral size of blood vessel. 
  
figure('Color',[1 1 1]); 
set(gcf,'Position',[0 0 18000 900]);  
vdepth=20;  
% width=7; %convolution width; only odd number  
  
for i=1:size(SV_C_c,3) 
% Emap=single(edge(SV_C_c(:,:,10))); %edge map;binary map; conv2 doesn't accetp logic 
map; 










SEmap(SEmap<110)=0; % converted to binary map 
SEmap(SEmap>=110)=1; 
L=bwlabeln(SEmap); % Labeled map; One distinctive number is assigned to each 
individual island in the SEmap 
  
for j=1:max(max((L))) 
    E=(L==j); 
    Area(j)=sum(E(:)); % the area of each island 
end 
label=find(Area==max(Area)); % finding the label assigned to the largest island  
% ROI(:,:,i)=(L==label); % The ROI is defined to largest island. 







    rowinitial=min(row);% start with the shallowest row 
    r=rowinitial+k-1; 
    if r>max(row) 
        break 
    else 
    rindex=find(row==r); 
    vwidth(k)=col(max(rindex))-col(min(rindex)); 

















OCT_s=Ind2RGB_Convert(sepia,OCT,[20 250]);  
DOCT_d=Ind2RGB_Convert(DOCT_Colormap,DOCT,[-pi pi]); 
SV_h=Ind2RGB_Convert(hot,SV,[0  600]);  
ROI_g=Ind2RGB_Convert(gray,ROI,[0 1]); 
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